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1  | INTRODUC TION
Innate and adaptive immune responses depend on the coordination 
and spatiotemporal control of leukocyte dynamics between and 
within lymphoid organs and peripheral tissues. A wide spectrum of 
chemically diverse molecules including small proteins, peptides, lip-
ids, nucleotides, and extracellular matrix fragments can act as che-
moattractants, regulating leukocyte motility, migration, chemotaxis, 
positioning, and cell- cell interaction. Leukocytes perceive these 
signals mainly through G- protein–coupled receptors (GPCRs) that, 
upon agonist binding, induce intracellular promigratory responses.1,2 
Based on the cell type–specific expression of cell surface GPCR type 
combinations and intracellular GPCR- controlling protein networks, 
each leukocyte subset has evolved specific trafficking paths to fulfill 
their designated effector functions in the body.3-5 Over the last de-
cades, the analysis of GPCR- deficient mouse models has advanced 
our understanding of how specific GPCR signals determine immune 
cell positioning and compartmentalization in situ. Recent work now 
also started to shed light on the establishment of chemokine pat-
terns and chemotactic fields that guide leukocytes in mammalian 
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Summary
G- protein–coupled receptor (GPCR) signaling is essential for the spatiotemporal con-
trol	of	leukocyte	dynamics	during	immune	responses.	For	efficient	navigation	through	
mammalian tissues, most leukocyte types express more than one GPCR on their sur-
face and sense a wide range of chemokines and chemoattractants, leading to basic 
forms of leukocyte movement (chemokinesis, haptokinesis, chemotaxis, haptotaxis, 
and chemorepulsion). How leukocytes integrate multiple GPCR signals and make di-
rectional decisions in lymphoid and inflamed tissues is still subject of intense re-
search. Many of our concepts on GPCR- controlled leukocyte navigation in the 
presence of multiple GPCR signals derive from in vitro chemotaxis studies and lower 
vertebrates. In this review, we refer to these concepts and critically contemplate 
their relevance for the directional movement of several leukocyte subsets (neutro-
phils, T cells, and dendritic cells) in the complexity of mouse tissues. We discuss how 
leukocyte navigation can be regulated at the level of only a single GPCR (surface ex-
pression, competitive antagonism, oligomerization, homologous desensitization, and 
receptor internalization) or multiple GPCRs (synergy, hierarchical and non- hierarchical 
competition, sequential signaling, heterologous desensitization, and agonist scaveng-
ing). In particular, we will highlight recent advances in understanding GPCR- controlled 
leukocyte navigation by intravital microscopy of immune cells in mice.
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tissues.6,7 In particular, intravital imaging of control and GPCR- 
deficient leukocytes in tissues of live anesthetized mice has brought 
unprecedented insight into the dynamic migration patterns of im-
mune cell subsets in situ.8,9 Despite these achievements, it is still 
largely unclear how leukocytes make directional decisions in lym-
phoid and inflamed organs where they constantly encounter GPCR 
signals emanating from multiple sources. The detailed mechanisms 
of how leukocytes sense, integrate, and prioritize between multiple 
chemotactic fields in situ and how this influences their physiolog-
ical trafficking are still largely unknown. Dissecting these molecu-
lar events experimentally in mammalian tissues is very challenging 
and demanding. In particular, we are missing important pieces of 
information (eg, the exact distribution and concentrations of known 
chemottractant, GPCR dynamics in leukocytes) and cannot control 
for unknown chemotactic fields. Due to these current limitations 
many of the emerging concepts for leukocyte navigation in complex 
chemoattractant milieus come from studies in controlled in vitro 
systems2 or lower model organisms.10,11 However, these concepts 
from reductionist models may not always be easily translatable to 
the complex situation in mammalian lymphoid organs and inflamed 
peripheral tissues. In recent years, several systematic studies in mice 
have started to disentangle how multiple GPCR signals shape leu-
kocyte migration patterns in the complexity of mammalian tissues.
In this review, we will summarize common concepts and mecha-
nisms of GPCR- controlled leukocyte navigation coming from studies 
with mouse and human leukocytes. We outline the protein networks 
that control GPCR signaling and GPCR activity and discuss how 
these may control leukocyte navigation strategies. In particular, we 
highlight our current knowledge on leukocyte navigation in complex 
chemoattractant fields and summarize them for three leukocyte 
subsets (neutrophils, T cells, and dendritic cells [DC]) with different 
physiological	trafficking	paths.	For	each	cell	 type,	we	will	critically	
evaluate the relevance of current concepts for leukocyte navigation 
in mouse tissue. While it is very likely that some navigation strate-
gies are only relevant for certain immune cell types and adapted to 
specific physiological tissue environments, leukocyte subsets may 
also share basic strategies for directional decision- making in lym-
phoid and inflamed tissues of mammals.
1.1 | Concepts and mechanisms of GPCR- controlled 
leukocyte navigation
Many chemokines and chemoattractants are classical inducers of leu-
kocyte polarity, adhesion, and locomotion. They act through GPCRs 
on intracellular signaling pathways to establish biochemical asymme-
try within the cell, preceding the formation of a polarized cell with an 
actin- rich front and a myosin II–rich rear.12,13 Key molecular pathways 
involved in establishing functional polarity downstream of GPCRs in 
leukocytes depend on phosphoinositide 3- kinases (PI3K) and mem-
bers of the Rho family of small GTPases.14 Rac isoforms, Cdc42 and 
RhoA represent major signal hubs that act through several effector 
molecules to regulate actin polymerization and actomyosin cytoskel-
eton. The balanced interplay of these components shapes the typical 
amoeboid migration mode of each leukocyte subset.15,16
In homogeneous fields of soluble chemokines and chemoattrac-
tants, most leukocytes undergo self- polarization, before increasing 
their motility, migration speed, and movement in a random and undi-
rected fashion (chemokinesis)	(Figure	1A).17 Chemokinesis is considered 
a migratory pattern that helps leukocytes scan large tissue volumes. 
We have learnt from intravital microscopy studies in mice that lym-
phocytes show such continuous undirected (random- walk) migration 
in lymphoid organs to enable encounters and interactions with other 
leukocytes.9 Together with other determining factors (eg, confinement 
between stromal tissue elements), uniform chemokine signals critically 
control chemokinesis by increasing the speed of randomly moving lym-
phocytes in situ.18 Once leukocytes perceive external gradients of sol-
uble chemokines and chemoattractants, they can perform directional 
movement along the concentration gradients of these diffusing at-
tractants (chemotaxis)	(Figure	1B).17 Some leukocyte subsets have also 
been reported to be repelled from high chemoattractant concentra-
tions (chemorepulsion), leading to their movement against the gradient 
(fugetaxis).19 However, the underlying molecular mechanisms of this 
F IGURE  1 General GPCR- controlled migration responses. (A) Homogeneous fields of soluble chemoattractants (chemokinesis) or 
surface- immobilized chemokines (haptokinesis) can induce leukocyte self- polarization and migration in a non- directed fashion. (B) Gradients 
of soluble chemoattractants (chemotaxis) or surface- immobilized chemokines (haptotaxis) can direct leukocytes toward higher attractant 
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process	 are	 still	 under	 investigation	 (Figure	1C).20,21 Apart from sol-
uble molecular cues, leukocytes also perceive surface- bound attrac-
tants as gradients or as homogeneous fields and undergo movement 
along these surfaces in a directed (haptotaxis)	(Figure	1B)	or	undirected	
manner (haptokinesis)	 (Figure	1A),	 respectively.16,22 The aspect of 
leukocyte navigation along surface- bound attractants is particularly 
relevant for chemokines with binding capacities to extracellular gly-
cosaminoglycans (GAGs), which decorate many stromal cell elements 
in tissues.22,23 This form of imprinting non- diffusible chemokine gra-
dients into the tissue has been shown critical for leukocyte trafficking 
across the blood endothelium and entry into lymphatic vessels.6,23 The 
terms “chemotaxis” and “haptotaxis” subsume a spectrum of navigation 
strategies, which leukocytes can use to follow attractant gradients.24 
When perceiving an external attractant gradient, some leukocytes (eg, 
unstimulated neutrophils in culture dish) undergo a full morphological 
change from unpolarized shape to the establishment of a front- back 
axis, which then leads to directional movement along the gradient. In 
contrast, other leukocytes already migrate with pre- established polar-
ity (eg, DCs and neutrophils in 3D), before they steer along the gra-
dient by redirecting their migration path. Alternatively, prepolarized 
leukocytes may move along a gradient without redirecting their path 
and start to accelerate the closer they get to the attractant source (eg, 
neutrophils in response to dying cells). Once at the highest attractant 
source, leukocytes may also actively decelerate and slow down their 
migration.24 As evidenced from intravital microscopy of select leuko-
cyte subsets, we know that this spectrum of chemotactic responses 
also occurs in mouse tissues. While we acknowledge that chemokines 
and chemoattractants are central for many aspects of these migratory 
responses, we are missing a detailed understanding about how these 
signals shape the navigation of leukocytes in situ. Is the cellular move-
ment guided by one or more attractant signal(s)? How do leukocytes 
navigate in complex gradient fields and sense the right direction? How 
do leukocytes sense their final destination and know where to stop? 
Are there inherent differences between leukocyte subsets in their nav-
igation strategies?
As many other cell types, leukocytes possess several mecha-
nisms that directly regulate the functionality of GPCRs.13,25-28 These 
are mainly controlled by GPCR interactions with three protein fam-
ilies: heterotrimeric (α, β, γ) G- proteins, G- protein–coupled receptor 
kinases (GRKs), and β- arrestins. Upon stimulation, a GPCR functions 
as a guanine nucleotide exchange factor that catalyzes the exchange 
of GTP for GDP on Gα subunits of the heterotrimeric G- protein. In 
leukocytes, Gα subunits of the pertussis toxin- sensitive Gi subfamily 
play critical roles for the signaling of many chemokine and chemo-
attractant receptors. The dissociation of Gβγ from Gα- GTP allows 
them both to independently activate downstream signaling path-
ways. Leukocyte chemotactic responses are largely controlled by 
the released Gβγ, which activates phosphoinositide 3- kinase (PI3K) 
and phosphoinositide- specific phospholipase Cβ (PLC)/inositol- 
trisphosphate (IP3)/diacylglycerol effector pathways.29,30
The termination of GPCR signaling relies on the intrinsic GTPase 
activity of the Gα subunit that hydrolyzes GTP and reassembles as 
Gα- GDP with Gβγ to form an inactive heterotrimer. This Gα GTPase 
reaction is accelerated by a family of proteins, called “regulators of 
G- protein signalling” (RGS proteins) to facilitate the rapid turning 
off GPCR signaling. Hence, RGS proteins are considered key de-
sensitizers of G- protein- signaling pathways.27 In addition, another 
negative feedback loop evolved to prevent the overstimulation of 
cells	through	excessive	GPCR	stimulation.	Following	agonist	binding	
and G- protein activation, GPCRs become rapidly phosphorylated 
on their cytoplasmic tails and intracellular C- termini by specific en-
zymes, usually members of the GRK family.31,32 The pattern of re-
ceptor phosphorylation creates a barcode with high- affinity binding 
sites for the recruitment of β- arrestin proteins.33 As a consequence, 
the increased binding of β- arrestin to the receptor sterically hinders 
the GPCR interaction with G- proteins. This uncoupling of G- proteins 
from the receptor, referred to as “receptor desensitization”, prevents 
further GPCR activation by repeated agonist stimulation over sec-
onds to minutes.34 β- arrestins can also control more long- lasting 
desensitization of GPCRs over minutes to hours. As they can inter-
act with clathrin- coated pits, their binding to GPCRs also targets 
receptors for internalization. Besides, GPCR internalization can also 
follow other pathways (arrestin independent, clathrin independent) 
or not occur at all.35 Depending on the intracellular trafficking route, 
the internalized receptors may be subject to degradation, leading to 
the downregulation of cell surface GPCRs. Alternatively, targeting 
internalized GPCR to recycling endosomes and back to the plasma 
membrane can quickly replenish GPCRs on the cell surface.35 In ad-
dition to their important roles in receptor inactivation and internal-
ization, GPCR- recruited β- arrestins also act as signaling mediators 
by directly coupling to numerous signaling molecules.36 At many 
GPCRs, β- arrestin- mediated signaling and classical G- protein sig-
naling can have distinct biochemical and physiological actions from 
one another. A relatively new paradigm on GPCR signaling considers 
the allosteric interaction among the ligand, the GPCR, and the trans-
ducers (β- arrestins and GRKs) and how their contribution influences 
the bias for G- protein– or β- arrestin–mediated signaling.28 Resulting 
from this paradigm, the concept of biased agonism, ie, that different 
ligands at the same GPCR are able to activate some signaling path-
ways while blocking others, is of particular interest for many chemo-
kine receptors with prominent roles in leukocyte navigation.37
In the following, we will point out the most commonly and 
recently discussed mechanisms, which would allow the control 
of leukocyte navigation. Given the before- mentioned regulation 
mechanisms for GPCR functionality, a “One- GPCR system” ap-
pears already sufficient to control chemokinesis and chemotaxis of 
leukocytes	(Figure	2A-	E).	To	increase	the	sensitivity	for	attractant	
gradients, leukocytes can upregulate the cell surface expression 
of GPCRs. Some leukocytes store GPCRs in intracellular vesicles, 
which can fuse with the plasma membrane under conditions of 
leukocyte activation.38 While the release of GPCR from vesicu-
lar stores occurs within minutes to hours, most leukocytes often 
respond to external stimuli by changing their cell surface GPCR 
profile over hours to days. These changes are primarily based on 
the induction of gene- transcription networks, which also include 
GPCR proteins, when leukocytes transition between cell states 
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or	undergo	differentiation	(Figure	2A).	Multimerization	of	GPCRs,	
including homomerization of the same GPCR type, provides an-
other level of GPCR regulation.25 A recent study highlighted the 
functional importance of GPCR oligomerization in promoting leu-
kocyte	 chemotaxis	 (Figure	2B).	 By	 lowering	 cellular	 cholesterol,	
inflammatory stimuli enabled GPCR oligomers that acted as scaf-
folds for distinct promigratory signaling pathways to foster effi-
cient leukocyte migration.39 However, GPCR multimerization has 
also been reported to dampen GPCR responsiveness.25 Several 
other mechanisms can attenuate the sensitivity of leukocytes 
for chemokines and chemoattractants. One involves the pres-
ence of a receptor antagonist that binds to the same GPCR as the 
gradient- forming attractant agonist, but exerts blocking function 
for	 promigratory	 signaling	 (Figure	2C).	More	 cell-	intrinsic	mecha-
nisms include the downregulation of GPCR expression by lower-
ing GPCR mRNA stability40 or enhancing GPCR degradation.41 As 
discussed above, agonist- induced receptor desensitization also 
attenuates the signaling responsiveness of GPCRs. Upon homol-
ogous desensitization, when GRKs phosphorylate agonist- specific 
GPCRs, the further recruitment of β- arrestins can lead to G- protein 
uncoupling	and	internalization	of	GPCRs	(Figure	2D).	This	process	
explains why many leukocyte chemotaxis responses toward single 
attractants are dose dependent and follow a bell- shaped curve, 
with higher concentrations resulting in stasis.42 Homologous de-
sensitization may be particularly relevant when leukocytes sense 
high attractant concentration in situ, eg, at the center of an attrac-
tant source.43 Under such conditions, the majority of cell surface 
GPCRs is likely to undergo desensitization, internalization, and 
degradation, which may then result in cellular unresponsiveness to 
continuous or repeated stimulation through the same attractant. 
As a strategy to remain responsive to subsequent stimulation in 
gradients, some leukocytes internalize GPCRs, deploy its ligand 
cargo into lysosomes, and quickly recycle unloaded GPCRs back to 
the plasma membrane.44 Thus, by eliminating chemotactic factors 
from the extracellular environments, classic GPCRs can acquire 
additional scavenging function. This “consumption” of external at-
tractant may also impact the chemotactic milieu by reducing the 
strength of attractant cues.44 Instead of only binding one agonist, 
many “One- GPCR systems” can bind and respond to two or more 
chemoattractants	 and	 activate	 downstream	 signaling	 (Figure	2E).	
Sensing these distinct attractants through the same GPCR in a spa-
tial or temporal sequence can provide another navigation strategy.
In our body, leukocytes are rarely exposed to only one chemo-
tactic	 factor.	 For	 efficient	 trafficking	 between	 organs	 and	 coordi-
nated movement within tissues, most leukocytes express more than 
one GPCR on their surface and sense a wide range of chemokines 
F IGURE  2 Regulation of G- protein–coupled receptor (GPCR) functionality in “One- GPCR systems”. (A) To increase responsiveness to 
a chemoattractant cue, leukocytes can upregulate the number of cell surface GPCR. This can occur rapidly by fusion of GPCR- containing 
vesicles with the plasma membrane (left) or with temporal delay by transcriptional control of GPCR expression (right). (B) The formation 
of homomers (dimers, oligomers, and multimers) can up- or downregulate the responsiveness to GPCR signals. (C) Receptor antagonists or 
partial agonists that bind to the same GOCR as the agonist can block or dampen promigratory signaling, respectively. (D) Agonist- induced 
receptor desensitization leads to G- protein uncoupling or GPCR internalization, and thus attenuates the signaling responsiveness of the 
GPCR. Depending on the intracellular trafficking pathway of the internalized loaded GPCR, receptors are either degraded or recycled back 
to the plasma membrane in their unloaded form. (E) Binding of more than one agonist can lead to ligand- biased GPCR signaling and the 
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and chemoattractants. Directional decision- making in lymphoid 
and inflamed organs requires leukocytes to constantly sense, com-
pare, and integrate numerous GPCR signals emanating from multi-
ple sources. To efficiently navigate in a complex milieu of attractant 
gradients, leukocytes need to respond to combinational signals and 
prioritize between competing signals. While this aspect of GPCR 
signal integration has already been of interest decades ago, it has 
regained momentum with the recent developments in fabricating 
microfluidic- based chemotaxis devices. We will now briefly summa-
rize common mechanisms and concepts for leukocyte navigation, 
which become already relevant in the presence of a second GPCR 
signaling	 system	 (“Two-	GPCR	 systems”)	 (Figure	3).	 As	 leukocytes	
often use combinations of more than two- GPCR systems, these 
principles could be further expanded.
Manifold scenarios of attractant interpretation are conceivable, 
when leukocytes sense two chemoattractant signals through two 
different	GPCR	types	(Figure	3).	The	outcome	for	leukocyte	guid-
ance depends on several determining parameters: (a) the spatial dis-
tribution of each signal (uniform, graded), (b) the spatial orientation 
of both signals toward each other (same or opposing directions), 
and (c) the ratio of signaling input that leukocytes receive from both 
signals (equal, unequal). The latter point includes both cell- intrinsic 
features and cell- extrinsic conditions. Unequal signaling input can 
result from different cell surface expression of the two- GPCR types 
F IGURE  3 Navigation strategies of leukocytes expressing two distinct G- protein–coupled receptor (GPCR) types (“Two- GPCR systems”) 
in complex chemoattractant fields. (A) Leukocytes exposed to a homogenous field of attractant 1 encounter a second- graded signal from 
attractant 2 that acts “on top”. (B) Leukocytes sense two attractant gradients that are oriented in the same direction and overlap, usually 
resulting in additive effects. (C) When leukocytes encounter two spatially opposing attractant gradients, the two GPCR signals may compete 
for guiding leukocytes into one or the other direction. Several factors determine the outcome of the directed migration response, some of 
which	are	depicted	in	Fig.	4	or	discussed	in	the	main	text.	(D)	Agonist-	independent	heterologous	receptor	desensitization	provides	one	form	
of GPCR crosstalk that leads to the dominance of one GPCR signal over others. (E) Step- by- step navigation through sequential chemotactic 
fields. When the two signals are spatially segregated, leukocytes first respond to signal 1 only, before maneuvering itself into a competitive 
situation	with	a	second	signal,	as	in	(C).	(F)	Two-	GPCR	systems	also	include	leukocytes	co-	expressing	a	signaling	GPCR	and	non-	signaling,	
scavenging GPCR for fine modulating the chemotactic response to one attractant agonist
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or different strength of the downstream signaling pathway. In both 
cases, one chemoattractant signal dominates over the other. This 
can also occur in leukocytes with equal signaling input from both 
GPCR systems under conditions of unequal concentrations of both 
signals in the extracellular space. Many of these scenarios have 
already been addressed with select leukocyte subsets and their 
cell- specific GPCR combinations in controlled in vitro microenvi-
ronments, and examples will be discussed in the next paragraphs 
about specific leukocyte subsets (neutrophils, T cell, and DCs). As 
discussed before, homogenous chemoattractant fields can induce 
leukocyte polarity and chemokinesis. A second- graded signal “on 
top” can then redirect prepolarized leukocytes and guide them 
toward other locations. However, if the uniform attractant field is 
very potent, it will retain leukocytes and attenuate chemotaxis to-
ward	 the	 second-	graded	 signal	 (Figure	3A).45-48 Under conditions 
when both attractant signals are oriented in the same direction 
and overlap, the two- GPCR signals have usually additive effects 
for	 leukocyte	chemotaxis	(Figure	3B).	 In	the	case	of	promigratory	
signals, chemotactic factors act often synergistically to improve 
chemotaxis along the same direction.49 Physiologically, this might 
be of particular relevance for tissue sites where overlapping attrac-
tant gradients originate from the same local area. A special variant 
of GPCR signal synergism has initially been observed in migrating 
human and mouse neutrophil populations in vitro. During their 
chemotaxis	in	response	to	shallow	N-	formyl-	peptides	(fMLF)	gradi-
ents, neutrophils released the lipid leukotriene B4 (LTB4) that acted 
on top of the early chemotactic factor as a signal relay molecule to 
improve chemotaxis of the whole neutrophil population.50 Under 
conditions when leukocytes encounter two spatially opposing gra-
dients, the two- GPCR signals compete for guiding leukocytes into 
one	or	the	other	direction	(Figures	3C	and	4).	Leukocytes	exposed	
to two opposing attractants with equal signaling strength will 
likely accumulate and find migratory equilibrium in the middle of 
both	gradients	(Figure	3C).47,48,51,52 However, an unequal signaling 
input from both signals favors the movement of leukocytes into 
one	direction	 (Figure	4A).47 It is known for decades that specific 
GPCR signals can dominate over other GPCR signals, which en-
ables leukocytes to prioritize some chemoattractant signals over 
others	 (Figure	4B).42,45 This aspect of GPCR crosstalk provided a 
first conceptual framework for neutrophils traveling in a stepwise 
fashion from the blood into infected tissues.45 Initially, it was dis-
cussed that heterologous desensitization of GPCRs might be an un-
derlying mechanism for prioritizing chemotactic cues. In contrast 
to homologous desensitization (see above), heterologous GPCR 
F IGURE  4 Prioritizing G- protein–
coupled receptor (GPCR) signals in 
opposing attractant gradients. Leukocytes 
exposed to two opposing signals with the 
same chemoattractive potencies will likely 
find migratory equilibrium in the middle 
of	both	gradients	(Fig.	3C).	Prioritization	
of one signal over the other can have 
several causes, with some examples 
depicted here: (A) Lower concentrations 
of attractant 1 lead to chemotaxis toward 
higher concentrations of attractant 2, 
given that both signals have the same 
chemoattractive potencies. (B) At the 
same concentration levels, one signal 
is dominant over the other, eg, due to 
heterologous desensitization or signaling 
hierarchies. (C) Single cell heterogeneity 
on the basis of cell surface expression of 
both GPCR types causes diverse single 
cell migration responses in a leukocyte 
population
Equal signal potencies,  
different concentrations 
Dominance of one signal 
same concentrations 
Single Cell Heterogeneity 
Equal signal potencies 
different concentrations 
     |  211LÄMMERMANN ANd KASTENMÜLLER
desensitization is agonist independent and results from the phos-
phorylation of one GPCR by a kinase activated through the signaling 
cascade	of	another	activated	GPCR	 (Figure	3D).	Thus,	one-	GPCR	
signal can act as desensitizing signal for multiple other GPCR types, 
causing leukocytes to become refractory to several chemotactic 
stimuli within minutes. This rapid cross- phosphorylation has been 
linked to second- messenger kinases, particularly protein kinase C, 
which phosphorylates the GPCR at sites different from GRKs.53	For	
neutrophil navigation in opposing gradients, it was later proposed 
that the dominance of certain GPCR signals is regulated by events 
downstream of the receptors. According to this concept, referred 
to as “signaling hierarchy”, special GPCRs induce intracellular sig-
naling pathways that can override signaling pathways downstream 
of other GPCR signals42,54 (see below for details). Leukocyte popu-
lations in tissues rarely consist of identical cell clones, but are rather 
characterized by many cells with slightly heterogeneous expression 
of GPCR combinations. Thus, single- cell heterogeneity on the basis 
of combinatorial GPCR expression may influence the population 
response in two opposing attractants with equal signaling strength 
(Figure	4C).	In	many	physiological	settings,	leukocytes	are	thought	
to navigate step- by- step through sequential chemotactic fields. 
Under conditions of two spatially segregated chemotactic signals 
in	 sequence	 (Figure	3E),	 leukocytes	 may	 first	 move	 along	 a	 first	
attractant	 gradient	 (Figure	1A),	 and	 then	 subsequently	 sense	 the	
gradient of a second, more distant attractant. During the transition 
from first to second attractant gradient leukocytes then encounter 
a	competitive	situation	between	two	gradients	(Figure	3C).	When	
the second signal is dominant over the first one, it is plausible that 
leukocytes are recruited to and then retained at the distant site. 
Importantly, even without any dominance between the signals, leu-
kocytes can migrate away from a first attractant and travel toward 
a second, more distant attractant.45 In principle, this also allows 
leukocytes to leave chemotactic fields of high, saturating concen-
trations. Moreover, leukocytes remain responsive for additional 
attractant changes, while moving back and forth in the equilibrium 
between both gradients. Thus, interpreting two distinct signals in 
sequence allows efficient navigation patterns that are not possible 
with only one attractant presented in the same spatial array. We 
want to point out that the sequential sensing of attractant gradi-
ents	can	also	be	temporally	controlled	(Figure	3E).	Leukocytes	may	
undergo sensing of a first attractant gradient, while a second at-
tractant arises newly in close vicinity. In the course of an immune 
response in lymphoid or inflamed tissues, this may result from che-
moattractant secretion of nearby activated tissue- resident cells 
or recently recruited, blood- derived leukocytes. As most immune 
responses are choreographed by a sequence of timely separated 
cellular events, it is likely that this aspect of sequential sensing has 
strong influence on leukocyte navigation in situ. In our contempla-
tion on leukocyte navigation by “Two- GPCR systems”, we have fo-
cused until now on GPCRs with signaling function. However, many 
leukocyte subsets additionally express members of the atypical 
chemokine receptor (ACKR) family on their surface. Also referred 
to as scavenging receptors, ACKRs are GPCRs with promiscuous 
binding affinity for multiple chemokines. As they do not couple to 
G- proteins, they are unable to induce intracellular signaling path-
ways. Instead, ACKRs can actively internalize and target chemo-
kines for lysosomal degradation.55	 Functional	 co-	expression	 of	
conventional chemokine receptors and ACKRs in leukocytes has 
been implicated in the fine- tuning of leukocyte chemotaxis, with 
ACKRs acting as rheostats in restricting excessive migration in re-
sponse	to	moderate	chemokine	levels	(Figure	3F).56-58
As we have just outlined, leukocytes have evolved several mo-
lecular mechanisms that allow an enormous spectrum of GPCR- 
controlled navigation strategies. Many of the emerging concepts for 
leukocyte navigation in complex chemoattractant fields have been 
developed in controlled in vitro systems, some of which by study-
ing only one select leukocyte subset. Rigorous testing and proving 
the relevance of these concepts for leukocyte migration in the com-
plexity of mammalian organs and tissues is technically very challeng-
ing. However, systematic studies in mice have started to delineate 
GPCR- controlled navigation strategies and their influence on phys-
iological trafficking patterns through lymphoid organs and inflamed 
peripheral tissues. In the following, we will discuss our current 
knowledge on the role of GPCR signals for the migration patterns of 
three leukocyte subsets (neutrophils, T cells, and DCs). Each of these 
immune cell types has evolved their own trafficking paths to fit their 
effector functions. We will highlight recent studies that conceptually 
advanced our understanding of GPCR- controlled leukocyte naviga-
tion in mammalian tissues.
2  | NEUTROPHIL S
Neutrophils are pivotal effector cells of our innate immune response 
and the first line of defense for eliminating bacteria and fungi in 
tissues.59 Recent studies also implicate regulatory functions of neu-
trophils in tissue homeostasis and cancer.60 In mammals, they are 
produced in the bone marrow and are continuously released into 
the bloodstream to patrol the intravascular compartment under 
homeostasis. Neutrophils circulate in the blood for ca. 12 hours 
under the influence of circadian rhythms, before they are mostly 
cleared into the bone marrow, but also other extramedullary 
tissues.61 In contrast to the general believe that naive peripheral 
tissues are free of neutrophils, recent work suggests that low num-
bers of neutrophils are present in many tissues under steady state.62 
Upon inflammation and infection, the release of neutrophils from bone 
marrow increases their concentration in the blood by several folds.63 
Moreover, large numbers of circulating neutrophils then infiltrate in-
flamed tissues where they sense activated vascular endothelium. In 
agreement with their critical role as first responders, neutrophils have 
evolved robust strategies to infiltrate inflamed tissues extremely fast 
and orient themselves to detect potential sites of microbial invasion 
with great precision. In many organs, the exit from the vascular com-
partment involves a sequence of exquisitely coordinated processes: 
(a) intravascular arrest, migration, and crawling along the activated 
endothelial cells, and (b) breaching multiple layers of the vascular wall 
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(venular endothelium, venular basement membrane, and pericytes).64 
Once neutrophils have traversed this barrier, they are primed for the 
rapid detection of damaged tissue or microbes in the extravascular 
space. At sites of cell death in the interstitial space, neutrophils un-
dergo sequential phases of highly coordinated chemotaxis and cell 
cluster formation, now commonly referred to as neutrophil swarm-
ing.65,66 As true sentinel cells, they sense almost any form of tissue 
insult, rapidly localize it in any inflamed organ and efficiently move 
toward the core of the inflammation or infection site. Neutrophils have 
been shown to express on their cell surface more than 30 GPCR types, 
which can all bind chemotactic molecules. Accordingly, neutrophils are 
responsive to a broad array of chemically diverse chemoattractants, in-
cluding chemokines, lipids, complement factors, formylated peptides, 
nucleotides, alarmins, and proteolytic (ECM) fragments.67-69 Many of 
these chemotactic factors are usually present at sites of in vivo in-
flammation. How the crosstalk between these GPCR signals guides 
neutrophil recruitment in inflamed tissues has been of huge interest 
since decades.
Early in vitro work with human polymorphonuclear neutrophils 
(PMN) characterized the strength of chemically distinct chemoat-
tractant classes to desensitize calcium- ion mobilization, as a read- 
out	of	GPCR	downstream	signaling,	to	one	another	(Figures	2D	and	
3D).53,70 Peptide chemoattractants, including N- formylmethionyl- 
leucyl-	phenylalanine	 (fMLF),	 the	 complement	 factor	 C5a,	 and	 the	
chemokine CXCL8 (IL- 8), cross- desensitized one another to different 
extents	(fMLF	>	C5a	>	IL-	8).	Moreover,	peptide	chemoattractants,	in	
particular	 fMLF,	 cross-	desensitized	 lipid	 chemoattractants,	 includ-
ing	platelet-	activating	factor	 (PAF)	and	LTB4.	 In	contrast,	 lipid	and	
purinergic agonists failed to desensitize to the peptide chemoattrac-
tants.70 These results were extended to neutrophil chemotaxis in the 
presence of multiple chemoattractants, showing a hierarchy of resis-
tance	to	competing	signals,	with	fMLF	and	C5a	inhibiting	migration	
to	 other	 chemoattractants	 (Figure	3D).71,72 Elegant under- agarose 
chemotaxis experiments proposed the concept that neutrophils 
can navigate through complex chemoattractant fields by migrating 
in a step- by- step manner in response to one agonist source after 
another. Thus, their ultimate positions are determined combinato-
rially by the array of GPCRs they express and by the sequence of 
chemoattractant	gradients	they	encounter	(Figure	3E).45 In this con-
cept, pathogen- derived “end- target” chemoattractants (N- formyl 
peptides, C5a) will dominate over host tissue- derived “intermediate- 
target” chemotactic factors (CXCL8, LTB4) in their ability to guide 
neutrophil	 migration	 (Figure	3A,	 C,	 E).45 This dominance of end- 
target attractants has been suggested to depend on the activation 
of the p38 MAPK pathway, which can override the phosphoinositide 
3- kinase (PI3K) pathway activated by intermediate- target attrac-
tants.42,54 Importantly, neutrophil navigation is also possible in a 
spatially sequential array of intermediate- target chemoattractants 
(Figure	3E).45,47,51,73 Another aspect of crosstalk between end- target 
and intermediate- target chemoattractants has not been considered 
in these early studies, but is also functionally relevant for neutro-
phil	navigation.	Already	small	amounts	of	fMLF	or	C5a	can	stimulate	
neutrophils to secrete intermediate- target attractants, in particular 
LTB4.50,74 This paracrine signaling mechanism becomes very relevant 
in chemotaxing neutrophil populations. Neutrophil- released LTB4 
functions as a signal relay molecule and amplifies in a feed- forward 
manner the chemotactic response to subsaturating concentrations 
of	 end-	target	 attractants	 (Figure	3B).50,75 Recent developments in 
microfabricated devices and microfluidic- based chemotaxis systems 
now allow a more detailed analysis of neutrophil migration responses 
in complex chemoattractant milieus, providing deeper insight into 
neutrophil	 navigation	 in	 opposing	 gradients	 (Figure	3C),47,73,76-78 
synergistic	 gradients	 (Figure	3B),49 and geometrically complex en-
vironments.49,77 Moreover, even the analysis of GPCR signaling un-
derlying neutrophil swarming dynamics is now possible due to novel 
micropatterning techniques.75 As human PMNs, mouse neutrophils 
express a range of functional GPCRs to sense N- formyl peptides 
(through	FPR1	and	FPR2),	C5a	(mainly	through	C5ar1),	LTB4	(mainly	
through LTB4R1/BLT1), and several chemokines including CXCL1, 
CXCL2, CXCL5 (through CXCR2), CXCL12 (through CXCR4), and 
several CC- chemokines (through CCR1).67 Some of these GPCRs are 
present in secretory vesicles that can rapidly fuse with the plasma 
membrane upon neutrophil activation, allowing the cells to increase 
their	 responsiveness	 to	 chemotactic	 cues	 (Figure	2A).38 Other re-
ported mechanisms to control GPCR functionality in neutrophils 
include	 competitive	 antagonism	 or	 partial	 agonism	 (Figure	2C),79 
receptor	multimerization	(Figure	2B),	differential	agonist	responses	
(Figure	2E),80 and agonist scavenging through simultaneous expres-
sion	of	ACKRs	(Figure	3F).56 Homologous desensitization is a well- 
known phenomenon for almost all neutrophil- expressed GPCRs 
(Figure	2D).	 While	 GPCR	 transducers	 (G-	protein	 subunit	 types,	
GRKs, and arrestins) and RGS proteins have been linked to the func-
tion of some GPCRs in primary mouse neutrophils,32,81-88 we are still 
missing a detailed understanding of their exact contributions to neu-
trophil navigation in complex chemoattractant fields.
Clearly, neutrophils are equipped with many GPCR types and 
mechanisms to dynamically control GPCR activity, allowing them to 
use various navigation strategies in the presence of multiple chemotac-
tic cues. Moreover, neutrophils have been shown to perform fugetaxis 
against the direction of a gradient of high concentration chemokine, 
a	 process	 that	 is	mechanistically	 not	well	 understood	 (Figure	1C).89 
However, there are still many open questions of how these mecha-
nisms contribute to the neutrophil migration patterns observed in situ. 
Intravital microscopy studies of GPCR- deficient neutrophils provided 
novel insight into how GPCR signals choreograph the physiological 
trafficking paths of neutrophils. In the following, we will point out that 
GPCR signals are important throughout many steps in the lifecycle of 
a neutrophil. In particular, we will highlight studies that advanced our 
concepts of GPCR- controlled neutrophil navigation in mouse tissues.
2.1 | Bone marrow release: inhibiting  
chemokine- mediated retention
The majority of mature neutrophils in the body reside in the bone 
marrow, with an estimated ratio of 300:1 between neutrophils 
in the bone marrow and blood. Neutrophil release into the blood 
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is controlled by the interplay of retention and mobilization sig-
nals, provided by two antagonistically operating chemokine sys-
tems	 (Figure	3A,C).	 During	 homeostasis,	 the	 chemokine	 CXCL12	
is produced in the bone marrow and essential for the retention of 
mature neutrophils that express the corresponding chemokine re-
ceptor CXCR4.90 CXCL12 is expressed at highest levels by “CXCL12- 
abundant reticular cells” (CAR cells), but also by other stromal cells 
of the bone marrow, including osteoblasts.63,91 The expression lev-
els of CXCL12 in stromal cells follow a circadian rhythm, controlled 
by the sympathetic nervous system.92 When neutrophils were 
freshly isolated from the bone marrow, they expressed only low 
levels of cell surface CXCR4, but contained high intracellular levels 
of CXCR4.90,93 After placing these cells in medium lacking CXCL12, 
they upregulated cell surface CXCR4 within hours.90,93 These find-
ings suggested receptor desensitization and internalization in re-
sponse to constitutively high local concentrations of CXCL12 in the 
bone	marrow	microenvironment	 (Figure	2D).	Moreover,	these	data	
underlined that neutrophils receive constant CXCL12 signals, which 
position them in the bone marrow, probably by activating integrin- 
mediated adhesion to stromal cells.94 While high concentrations of 
CXCL12 retain neutrophils in the bone marrow via CXCR4 signal-
ing, low concentrations of CXCR2 ligands expressed on endothelial 
cells and produced by megakaryocytes facilitate neutrophil egress 
via CXCR2.63 Thus, CXCR2 signals recruit neutrophils out of the 
retentive CXCL12 field and direct them to the endothelial sinus 
walls	for	entry	into	the	blood	circulation	(Figure	3A).	This	intricately	
balanced interplay between retention and mobilization signals can 
be	shifted	 in	both	directions.	G-	CSF	treatment	or	acute	 inflamma-
tion,	which	 increases	 blood	 serum	 levels	 of	G-	CSF	 and	CXCR2	 li-
gands, shifts the balance toward neutrophil mobilization from the 
bone marrow.95-98 Several modes of action have been proposed for 
G-	CSF,	either	leading	to	the	lowering	of	CXCL12	levels	in	the	bone	
marrow or triggering the release of CXCR2 ligands from endothelial 
cells or megakaryocytes (summarized in63). The same shift toward 
neutrophil egress can be achieved by conditional gene depletions 
of CXCR4 or CXCL12 in mice.99,100 The administration of the CXCR4 
antagonist AMD3100 also results in a threefold increase in the num-
ber of circulating neutrophils and a corresponding decrease in bone 
marrow numbers.93,101 Originally, this drug effect was interpreted as 
direct antagonism of CXCR4 expressed by neutrophils, thereby dis-
rupting	the	CXCL12-	CXCR4	axis	in	the	bone	marrow	(Figure	2C).90 
Surprisingly, subsequent studies found that AMD3100 also acted on 
CXCR4 expressed by bone marrow endothelial cells, and inhibited 
the translocation of CXCL12 across bone marrow endothelial cells, 
suggesting a rapid rise of CXCL12 in the blood and reversal of the 
CXCL12	gradient	(Figure	3B).102,103 These data were questioned by 
intravital imaging studies that could not observe clear neutrophil 
egress from the bone marrow upon AMD3100 treatment. Instead, 
the increase in circulating neutrophils through AMD3100 was ex-
plained by the release of marginated neutrophils from the lung mi-
crovasculature.104 Moreover, AMD3100 had a blocking effect on the 
trafficking of aged blood neutrophils, which upregulate CXCR4 ex-
pression over time, enabling them to home back to the bone marrow 
for clearance.104 The exact mode of action of AMD3100 is still con-
troversially discussed.90
Insight into the physiological consequences of shifting the 
chemokine balance in the opposite direction, toward retention in 
the bone marrow, comes from an extremely rare congenital human 
immunodeficiency disease. Warts, hypogammaglobulinemia, infec-
tions, and myelokathexis (WHIM) syndrome is an autosomal dom-
inant human disorder caused by gain- of- function mutations in the 
C- tail of CXCR4.105,106 WHIM syndrome involves myelokathexis, a 
condition characterized by the retention of mature neutrophils in the 
bone marrow and peripheral neutropenia. WHIM- associated trun-
cations or mutations in the carboxy- terminal tail of CXCR4 result in 
the loss of multiple serine residues, which are target sites for GRK- 
mediated receptor phosphorylation. Truncated forms of CXCR4 
are impaired in agonist- induced homologous desensitization and 
internalization, and cause enhanced signaling upon CXCL12 stimula-
tion.106 This leads to stronger anchorage of mature neutrophils in the 
bone marrow, counteracting CXCR2- mediated chemotaxis toward 
vessels	 and	 neutrophil	 egress.	 However,	 administration	 of	 G-	CSF	
or ADM3100 to WHIM patients can overcome this imbalance and 
cause an increase in circulating neutrophil numbers.106
2.2 | Getting to the site of inflammation: navigation 
along multiple chemokine fields
Blood- circulating neutrophils detect sites of tissue injury and infec-
tion by interacting with the luminal surface of activated venular en-
dothelium. In response to tissue- released inflammatory cytokines, 
endothelial cells upregulate P- selectin, E- selectin, and integrin li-
gands, such as ICAM- 1 and VCAM- 1, to promote interactions be-
tween neutrophils and the vessel wall. This induces neutrophils to 
undergo a multistep adhesion cascade along the endothelial lining 
before emigrating from the vessel into the inflamed tissue interstit-
ium.107 Chemokines are present on the luminal surface of endothelial 
cells and cause arrest of rolling neutrophils by triggering the activa-
tion of integrins. Many studies showed an involvement of CXCR2 
ligands, in particular CXCL1, but also CXCL2 and CXCL5, in this pro-
cess.108,109 These chemokines are primarily expressed and released 
by endothelial cells,110,111 but also tissue- resident cells, including 
pericytes, perivascular macrophages, and mast cells, can act as im-
portant chemokine sources.112-115 Due to their high- affinity binding 
sites for heparin sulfate (HS) GAG most chemokines become immo-
bilized by HS GAG on the luminal side of the endothelium,116 and 
defects in HS GAG synthesis have been shown to decrease immobi-
lization of chemokines and neutrophil transmigration into inflamed 
tissues.117,118 While the involvement of chemokines for neutrophil 
transmigration is widely established, there has been ongoing debate 
whether and how leukocytes sense stable chemokine gradients 
across	the	vessel	wall	on	their	way	into	the	tissue	(Figure	1B).	There	
are ample references to support the common believe that chemotac-
tic gradients between the apical and basolateral part of postcapillary 
venules promote diapedesis, ie, the outward passage of neutrophils 
through the vessel wall. Immunofluorescence stainings of HS GAG 
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moieties revealed steep gradient of HS GAG scaffolds between the 
luminal and abluminal aspect of skin postcapillary venules.119 Under 
inflammatory conditions, HS GAG distribution became even more 
polarized by massive depositions of HS and laminin in the basolat-
eral basement membrane of skin vessels.119 Given the GAG- binding 
properties of many chemokines, it was proposed that these sharp 
HS GAG scaffold gradients might favor chemokine gradients across 
the venular wall. In agreement with this idea, excessive deposition of 
the GAG- binding chemokine CXCL1 on the apical part of inflamed 
blood vessels resulted in decreased neutrophil diapedesis.120 Other 
supporting data come from experiments in which an extravascular 
source of CXCR2 ligands was placed in form of a gel on one side of a 
blood vessel.121 Under these conditions, neutrophil crawling was di-
rected to emigrate preferentially from that side of the vessel. HS GAG 
on the surface of the endothelium was required to present CXCL2, 
forming a chemotactic gradient that was followed by neutrophils. 
This sequestration of endothelial chemokine occurred exclusively in 
venules, but not other blood vessel types.121 HS GAG, together with 
the atypical receptor ACKR1, was also discussed to establish gradi-
ents by transcytosis of chemokines.118,122,123 Transcytosis involves 
the internalization and transport of tissue- derived inflammatory 
chemokines from the basal surface onto the luminal surface of en-
dothelial cells. ACKR1 is specifically expressed by postcapillary ven-
ules and was shown to support promigratory chemokine patterns 
across the vessel wall for optimal leukocyte migration across the 
vessel wall.123,124 Unlike other ACKR, ACKR1 does not act as classical 
scavenger receptor, and was initially discussed to promote the tran-
scytosis of tissue- derived inflammatory chemokines from perivascu-
lar pools to the apical surface of venules.122,123 Novel insight into the 
functional role of ACKR1 and the directional cues that guide neu-
trophils during diapedesis come from recent elegant experiments 
of Nourshargh and colleagues.125	 By	 studying	 TNF-	induced	 neu-
trophil emigration in the inflamed mouse cremaster muscle, it was 
shown that neutrophils encounter the two CXCR2 ligands CXCL1 
and CXCL2 in a sequential manner during their passage through the 
vessel wall. In a three- step process, neutrophils first sense CXCL1 
produced	by	TNF-	stimulated	endothelial	cells	on	the	luminal	surface	
of venules, promoting crawling along the endothelium. Next, neutro-
phils encounter CXCL2 that is retained at endothelial cell junctions 
by ACKR1. Notably, CXCL2 is secreted by neutrophils themselves 
and then presented by ACKR1, which is enriched in endothelial junc-
tions. This self- guided migration response of neutrophils was critical 
for breaching of endothelial junctions and unidirectional transen-
dothelial migration. Lastly, CXCL1 expressed by pericytes governed 
neutrophil crawling in the subendothelial space.125 While earlier 
work indicated relatively restricted expression of CXCL1 to vascular 
and tissue- resident cells, and CXCL2 with activated neutrophils,126 
these novel findings highlight unexpected non- redundant roles for 
CXCL1 and CXCL2 to guide neutrophils through venular walls as 
governed by their distinct cellular sources.125 Having identified this 
critical spatiotemporal sequence of chemokine- guided steps across 
the	vessel	wall	(Figure	3E),	it	will	be	of	future	interest	to	understand	
how other tissue- derived attractant signals may act on top of this 
and support further guidance into the underlying inflamed interstit-
ium. As an example, neutrophils entering an inflamed peritoneum 
were suggested to encounter two sequential gradients in a step- by- 
step	manner	(Figure	3E).114 In a lipopolysaccharide- induced perito-
nitis model, initial recruitment of neutrophils out of the blood vessel 
into the peritoneal tissue was regulated by rapid secretion of CXCL1 
and	CXCL2	from	perivascular	mast	cells.	Further	guidance	of	extrav-
asated neutrophils through the interstitium and into the peritoneal 
cavity depended on CXCL1 and CXCL2 produced by tissue- resident 
interstitial macrophages.114
2.3 | Getting to the site of inflammation: 
interpreting temporal cascades of chemically distinct 
chemoattractants
Most of our discussions until now focused on the role of chemokines 
for neutrophil guidance in the tissue, but also putative non- GAG- 
binding, soluble chemoattractants including C5a, LTB4, and for-
mylated peptides are sensed by neutrophils and relevant for special 
types of inflammatory reactions. A mouse model of autoimmune 
rheumatoid arthritis, the K/BxN serum transfer model, has provided 
unprecedented insight into how four different chemoattractant re-
ceptors, C5aR1, LTB4R1, CCR1, and CXCR2, collaborate to recruit 
neutrophils into the inflamed tissue.127 In this model, the inflamma-
tory response is driven by immunoglobulin G autoantibodies to the 
ubiquitous glycolytic enzyme glucose- 6- phosphate isomerase (GPI) 
leading to the formation of immune complexes that drive immune 
cell activation. Neutrophil infiltration into the joint is critical for the 
clinical signs of arthritis in this model. Several consecutive studies 
have elucidated a temporal cascade in which neutrophils encoun-
ter complement, lipid, and chemokine signals to enter the joint and 
contribute	 to	disease	progression	 (Figure	3E).74,128-131 While it has 
long been known that immune complexes lead to the activation of 
the alternative complement system in arthritis,132,133 it has only re-
cently been found that C5aR signaling in circulating neutrophils is 
the key initiator for a cascade of events that ignite inflammation.131 
The deposition of immune complexes in the joint space induces the 
generation of C5a, which unexpectedly binds to HS GAG on the 
synovial endothelium. Neutrophils sense C5a on the joint endothe-
lium, induce integrin- dependent arrest, and facilitate crawling along 
the vasculature. Subsequently, C5a signals stimulate neutrophils to 
secrete LTB4, which induces the entry of the first neutrophils into 
the joint and initiates the onset of disease.74,128,129,131 After disease 
onset, recruited neutrophils in the joint secrete IL- 1β, which in turn 
stimulates fibroblast- like synoviocytes to produce CCR1 ligands at 
first and later CXCR2 ligands.130 CCR1 ligands are required to recruit 
the next wave of neutrophils into the joint, and this recruitment of 
neutrophils is broadly amplified in the last step of the cascade when 
neutrophils themselves release CXCL2 to potently attract large 
numbers of neutrophils into the joint.67,130
Thus, neutrophil entry into the inflamed joint is a prime example 
where neutrophil recruitment is choreographed by non- redundant 
roles of distinct chemoattractants that collaborate sequentially in a 
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temporal	cascade	(Figure	3E).	Moreover,	this	process	highlights	the	
rapid production of complement and LTB4 to initiate a recruitment 
cascade at the local site of inflammation. By contrast, chemokines 
act later in this cascade to amplify and prolong the inflammatory 
response.67
2.4 | At the site of inflammation: synergism through 
lipid- mediated amplification
Another example where complement- induced LTB4 secretion rap-
idly shapes neutrophil migration patterns has recently been de-
scribed.134 In a simplified fungemia mouse model, the fungi Candida 
albicans sequestered in the pulmonary vaculature and actively 
recruited neutrophils. Neutrophils showed swarm- like migration 
patterns in response to sequestered yeast, similar to previously de-
scribed swarming responses in other tissues.66 A small number of 
lung neutrophils responded within minutes and performed intra-
vascular chemotaxis, before larger numbers of neutrophils were re-
cruited and formed cell clusters. The immediate capture of live C. 
albicans by neutrophils depended on complement- mediated chemo-
taxis.134 In addition, complement activation stimulated neutrophils 
to secrete LTB4, which amplified the directional recruitment and 
clustering	 of	 neutrophils	 in	 a	 synergistic	 manner	 (Figure	3B).	 This	
was in agreement with a previous study highlighting the importance 
of LTB4- mediated signal amplification during neutrophil swarm-
ing in interstitial tissue spaces at sites of sterile skin injury and in 
bacteria- infected lymph nodes.135 Neutrophil swarming is an essen-
tial process of the neutrophil tissue response and has been observed 
in diverse tissues under conditions of sterile inflammation and in-
fection with various pathogens, including bacteria, fungi, and para-
sites.65,66 The swarming response comprises sequential phases of 
highly coordinated chemotaxis followed by neutrophil accumulation 
and the formation of substantial neutrophil clusters, which has led 
to the multistep attraction model of neutrophil swarming.66 While 
the underlying signals and molecular players for some of these steps 
are still unclear, we know that neutrophil- derived LTB4 acted on top 
of early released, yet unknown, chemoattractants and mediates in-
tercellular signal relay among neutrophils to amplify interstitial re-
cruitment	in	a	feed-	forward	manner	(Figure	3B).	This	model	was	in	
accordance with earlier in vitro studies identifying LTB4 acted as a 
signal relay molecule (see above).50 As a consequence, LTB4- LTB4R1 
signaling enhances the radius of neutrophil recruitment from distant 
tissue sites and maintains the amplified chemotactic response of 
the neutrophil population. Together with signaling through other 
GPCRs,	such	as	CXCR2	and	FPR2,	LTB4R1	signaling	also	optimizes	
neutrophil clustering.135 Importantly, LTB4 and CXCR2 signals are 
also relevant for the swarming response of human neutrophils.75 
The formation of focalized dense neutrophil aggregates is consid-
ered beneficial for isolating sites of tissue wounding from viable 
surrounding tissue, containing microbial invaders and concentrat-
ing the microbicidal activity of a whole neutrophil population in one 
swarm center.66 However, neutrophil aggregation can also lead to 
tissue damage and removal of other cells.135,136 In the context of 
the lung microvasculature, intravascular neutrophil swarms that 
formed in response to C. albicans infection lead to vessel occlusion 
and pulmonary hemorrhages, which were reverted in the absence 
of LTB4R1.134 How neutrophil- derived LTB4 shapes and maintains 
a promigratory chemotactic field in vivo remains unclear. LTB4 is 
considered to have a short half- life and can be rapidly turned into 
LTB4 metabolites, which act as natural inhibitors of LTB4- mediated 
responses. However, it has also been demonstrated that neutrophils 
release LTB4 in form of exosomes, which may support more pro-
longed effects of LTB4 gradients.137 Interesting insights into this 
issue come from studies with diabetic mice receiving skin infec-
tions with methicillin- resistant Staphylococcus aureus (MRSA), which 
leads to large neutrophil clusters in form of abscesses.138 Diabetic 
mice produce higher levels of LTB4 in the infected skin compared 
to non- diabetic mice. Surprisingly, neutrophils in the skin of these 
mice failed to assemble into an organized abscess, as excessive LTB4 
levels likely disrupted chemoattractant gradients in the skin and im-
paired directed neutrophil chemotaxis.138 These findings exemplify 
that the appearance or absence of neutrophil swarms depends on 
the specific mixture of chemoattractants in a specific inflammatory 
environment. Although not yet studied in detail, we know that sev-
eral factors, including tissue damage size, presence of pathogens, 
induction of cell death, and neutrophil numbers, are important for 
shaping the exact neutrophil- swarm phenotype in an inflamed tis-
sue. All these factors can potentially initiate the release of chemot-
actic fields that may strengthen or attenuate LTB4- mediated signal 
amplification in situ.66
2.5 | Getting to the site of inflammation: following 
hierarchies
True prioritization of chemoattractant fields has been observed 
for neutrophils in a model of thermal- induced liver injury.139 In this 
model, large numbers of neutrophils are recruited over hours from 
the liver sinusoids to a focal site of sterile hepatic necrosis. The ne-
crotic area releases several molecules that shape the adjacent he-
patic environment and ultimately form two distinct chemotactic 
fields at different distances from the necrotic focus. During their 
search for damaged tissue neutrophils sequentially navigate through 
these	two	chemotactic	fields.	First,	neutrophils	follow	an	intravas-
cular gradient of GAG- bound immobilized CXCL2 that supports 
integrin- dependent crawling toward the necrotic focus. This CXCL2 
haptotactic gradient abruptly halts, approximately 150 μm proximal 
to the border of the necrotic tissue. Second, neutrophils at this bor-
der continue to migrate on top of platelets along non- perfused vas-
culature, before entering the necrotic area.139,140 When neutrophils 
were	lacking	the	formyl-	peptide	receptor	FPR1,	they	migrated	along	
the healthy sinusoids to the highest concentration at the end of the 
haptotactic CXCL12 gradient and never entered into the platelet- 
rich	and	following	necrotic	zone.	Given	the	important	role	of	FPR1	
signaling during this process, mitochondrial- derived formyl peptides 
released from dying hepatocytes were suggested to attract neutro-
phils	into	the	necrotic	area.	Of	interest,	FPR1	signaling	has	also	been	
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shown to regulate neutrophil recruitment into necrotic areas of he-
patic ischemia- reperfusion injury.141 In contrast to formyl peptides 
released from bacteria, endogenous formyl peptides are produced by 
mitochondria and become released upon cellular damage.142 Similar 
to bacterial formyl peptides, also mitochondrial formyl peptides can 
promote	neutrophil	chemotaxis	in	an	FPR-	dependent	manner.139,142 
Thus, neutrophil navigation in the liver injury model follows a spa-
tial	cascade	of	chemoattractants	(Figure	3E)	and	appears	to	depend	
on	the	prioritization	of	an	end-	target	attractant	(eg,	fMLF)	over	an	
intermediate-	target	 attractant	 (eg,	 CXCL2)	 (Figure	3A).	 Recent	 el-
egant work by Kubes and colleagues revealed that neutrophils play a 
critical role in fully repairing the hepatic injury. In the course of this 
process, neutrophils at the border of the injury left the injury site 
and reentered healthy liver sinusoids.143 However, it remains to be 
shown if GPCR- controlled mechanisms are involved in this form of 
reverse migration into the vasculature.
3  | T CELL S
T cells and B cells represent the cellular hallmark of the adaptive 
immune system. These lymphocytes are generally long- lived cells 
and are driven by GPCR- mediated guidance throughout their life 
cycle. Being released from the bone marrow as a common lymphoid 
progenitor, T- cell precursor settle in the thymus where they tread 
a highly regulated developmental path, guided by GPCRs. Once T 
cells have been fully matured and selected, they exit the thymus and 
commence their recirculation pattern between secondary lymphoid 
organs (SLO). As the T- cell receptor (TCR) repertoire needs to be 
highly diverse in order to raise the chance to efficiently detect for-
eign antigens against all kind of pathogens, the naive T- cell precursor 
frequency	for	a	specific	antigenic	determinant	is	very	low	(≈1/105- 
1/106). Consequently, during a newly arising infection, antigen- 
presenting DC need to interact with millions of T cells in order to 
activate the few rare naive T cells that optimally react to the foreign 
antigenic determinant. To facilitate this process T cells need to ef-
ficiently migrate between and navigate within SLOs to optimize such 
DC encounters. Once T cells are activated and primed by a DC carry-
ing and displaying the proper antigen, they differentiate and change 
their GPCR expression pattern in order to leave the SLO and enter 
infected tissues via the blood stream. Here, GPCRs pilot them to-
ward infected cells where they execute their specific effector func-
tion in order to eliminate or at least control the microbial invasion.
In vitro experiments to address how lymphocytes respond to 
chemokines were primarily based on transwell, under agarose as-
says or 3D ECM- like gels, showing that chemokinesis, chemotaxis, 
and homologous and heterologous desensitization apply to GPCR- 
mediated navigation of T cells.144-149 However, these approaches 
have limitations when trying to address how T cells respond to more 
complex chemokine fields involving multiple GPCRs. With the de-
velopment of microfluidic devices150 and more recently, microfluidic 
mazes, T- cell exploratory patterns and chemotaxis in response to 
chemokines could be analyzed in more detail, while providing the 
investigator with a higher level of control and precision.151 Overall, 
however, there are only a few studies that have addressed complex 
GPCR interactions in T cells in vitro. In the following sections we will 
focus on what we have learned from in vivo experiments regarding 
the trafficking of T cells.
3.1 | Searching for the antigen: exploration and 
compartmentalization
In vivo, chemo- and haptokinesis are particularly prevalent in lym-
phoid organs and underlie the continuous undirected or random- 
walk	 migratory	 activity	 of	 lymphocytes	 (Figure	1A).9	 Functionally,	
this migratory behavior is required to enable encounters and consec-
utive interactions between leukocytes. In other words it reflects the 
search strategy of lymphocytes to detect rare interaction partners 
in a large and densely populated three- dimensional space. Given the 
low precursor frequency of lymphocytes, such migratory behavior 
was predictable; yet direct visualization of lymphocyte migration by 
means of intravital two- photon microscopy fundamentally changed 
our perception how lymphocytes navigate and interact with their 
environment in complex tissues.8,152 This migratory behavior of T 
cells in vivo is regulated by several factors (for review see153). (a) T 
cell- intrinsic molecules that regulate cellular polarization, protru-
sion formation, and turning patterns,154-156 (b) physical constraints 
and guiding structures formed by stromal elements and the extra-
cellular environment,157 (c) intercellular adhesive forces158, and (d) 
chemokinetic cues.159 The central chemokines and receptors that 
drive chemo- /haptokinesis of lymphocytes in lymphoid organs are 
CCL19/CCL21- CCR7, CXCL13- CXCR5, CXCL12- CXCR4, and LPA- 
LPAR2. Interestingly, these chemokines appear to primarily regulate 
the speed of migrating cells rather than their migratory pattern. In 
particular, CCR7- deficient T cells showed about 30%- 50% reduced 
T- cell speed in LN explants as well as in situ.18,160-162 Additional 
blockade of CXCR4 did not further decrease lymphocyte speed ar-
guing that other factors than chemokines regulate the basal migra-
tory speed of lymphocytes in the steady state.162,163 Indeed, two 
recent studies provided direct evidence that LPA (lysophosphatidic 
acid) contributes to the migrational speed of CD4 T cells in the lymph 
under steady- state conditions.164,165 Using intravital microscopy 
both studies showed that Lpar2- deficient CD4 T cells have a reduced 
migrational speed and spatial displacement as compared to wt CD4 
T cells. These results add to the concept that T cells not only inter-
pret multiple chemokines but in addition lipid signals, which together 
organize the localization, the migrational speed, and the search pat-
tern of lymphocytes in SLO.
Overall, chemo- and haptokinesis are key elements of lympho-
cyte migration within SLO. By contrast, chemo- and haptotaxis are 
critical mechanisms that lymphocytes utilize in order to travel be-
tween tissues and find their specific destination within microana-
tomical	niches	(Figure	1B).	In	the	steady	state	chemotactic	migration	
of T cells typically reflects the integration of several conflicting sig-
nals detected by multiple GPCRs, like the recirculation pattern of 
T cells that is regulated by exit vs retention cues, as we will discuss 
     |  217LÄMMERMANN ANd KASTENMÜLLER
in more detail below. In the following paragraph, we will discuss in-
stances of chemotaxis of T cells that are dominated by single recep-
tors assuming that potentially competing signals may be functionally 
negligible in these examples.
In the steady state T- cell subset distribution within the LN or 
the	white	pulp	of	the	spleen	is	inhomogeneous.	For	example,	it	has	
been observed that the localization between CD4 and CD8 lym-
phocytes in the white pulp of the spleen is not fully overlapping.166 
Specifically, CD8 T lymphocytes populate more densely the deep 
paracortex, while CD4 T lymphocytes are located in slightly more 
peripheral areas of the white pulp or the LN paracortex, respectively. 
Gpr183- mediated chemotaxis is likely the basis for this differential 
localization. CD4 T cells express significantly higher levels of Gpr183 
than CD8 T cells and the ligands for Gpr183, oxysterols, are emitted 
at the interfollicular area (and the bridging channel of the spleen). 
Reminiscent to the differential localization of T lymphocytes, ox-
ysterols regulate the localization of cDC2 in contrast to cDC1 that 
are more abundant in the deep paracortex.167-169 However, in prin-
ciple, differential localization in the SLO may also be explained via 
the engagement of another GPCR in particular CCR7. The peculiarity 
of SLO compared to other organs is that the majority of its cellular 
elements (lymphocytes) are constantly in motion in a chemokinetic 
manner as discussed above. Therefore, in principle in a 3D- space, 
which is homogenously populated by a heterogeneous group of cells, 
relocalization of one group of cells could be either active or passive 
(Figure	5).	Active	migration	 reflects	 the	 chemotactic	migration	 to-
ward a newly arising chemokine gradient. Passive migration reflects 
a crowding- out effect of cells in a limited space by incoming cells that 
may themselves follow a chemotactic gradient. We have observed 
such a crowding- out effect in inflammatory conditions. Specifically, 
we compared the behavior of memory vs naive antigen- specific T 
cells in the context of viral infections of the LN.170 In non- competitive 
settings, naive antigen- specific CD8 T cells rapidly (within 4- 8 hours) 
detect and co- arrest with antigen- bearing APCs in the interfollicu-
lar area. In the presence of antigen- specific memory CD8 T cells, 
we observed a significant decrease in naive antigen- specific CD8 
T cells numbers in the interfollicular area starting about 100 min 
postinfection. This coincided with a strong influx of memory CD8 T 
cells based on CXCR3- mediated chemotactic cues arising from the 
SCS area.170,171 Although not directly addressed in these studies, 
the observed relocalization of naive CD8 T cells in the context of 
incoming memory CD8 T cells is well explained by a crowding- out 
model	(Figure	5).	These	dramatic	effects	observed	during	inflamma-
tory conditions may also apply in the steady state. CCR7- mediated 
signals support chemokinesis in the LN. However, there are indica-
tions that CCR7 also acts on a chemotactic level in the steady state 
guiding	responding	cells	to	the	center	of	the	LN.	For	example,	LN-	
resident cDC1 that get activated at the interfollicular area migrate 
to the deep paracortex upon maturation and CCR7 upregulation.172 
Vice versa, Tfh cells that search for interacting B cells at the T/B 
border downregulate CCR7 to reach this area and upregulate CXCR5 
to enter the B- cell follicle as a second step.173	Consistently,	FRC	(fi-
broblastic reticular cells) at the T/B border produces less CCL19 than 
their counterparts in the paracortex.174 Similarly, we observed that 
memory CD8 T cells express lower levels of CCR7 and are located 
at peripheral areas of the LN paracortex. By contrast to naive CD8 T 
cells that express higher levels of CCR7 and populate the deep para-
cortex.170 So memory CD8 T cells may in part be displaced (crowding 
out) from the deep paracortex by naive CD8 T cells that experience 
a stronger chemotactic attraction to this area.
Chemotaxis not only regulates the localization of conventional 
T cells but also navigates NK cells and invariant T cells in SLO. 
Functionally,	these	lymphocytes	are	localized	in	closer	proximity	to	
lymphatic sinuses in order to promote a more rapid response against 
lymph- borne pathogens, which is essential to avoid microbial dis-
semination.175,176 Invariant T cells are attracted to SCS via CCL20- 
CCR6–mediated chemotaxis.177 CCL20 is produced by the lymphatic 
endothelium generating a gradient across the sinus floor. This gra-
dient guides CCR6- expressing T cells toward sinus- lining macro-
phages that in turn provide them with IL1 and IL23 in the context 
of infections.
Most of the above examples identified chemotaxis indirectly, 
meaning by the differential localization of cells in the absence of a 
specific chemokine receptor. However, in the context of inflamma-
tion also direct evidence for chemotaxis of T cells has been found. 
Here, chemotactic signals may become dominant, both in a quanti-
tative or qualitative manner making it easier to observe alterations 
F IGURE  5 Crowding out vs active migration. In a 3D space 
that is homogeneously populated by, eg, two different groups of 
cells, a redistribution and niche occupation is typically achieved 
by active migration toward a chemoattractant gradient by both 
groups of cells. However, if both cell populations have a baseline 
chemokinetic activity, redistribution of both populations may 
be based on the directional migration of only one population. 
The other population can passively redistributed due to space 
limitations (crowding- out effect)
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in migratory behavior of T cells in a rapidly changing environment. In 
contrast to neutrophils or DC that show a high degree of direction-
ality toward a chemotactic gradient, T cells rather show a meander-
ing motion toward their target. However, occasionally T cells make 
directional jumps as direct evidence for chemotaxis. This has been 
directly visualized in the context of CCR5- and CXCR3- mediated 
signals.170,171,178,179
3.2 | Recirculation: modulation of sensitivity
Homologous receptor desensitization as a means to regulate GPCR 
signaling	is	a	well-	established	concept	in	vitro	(Figure	2D).	In	particu-
lar, chemokine receptor internalization on T cells has been demon-
strated for CXCR4, CCR7, CCR5, and CXCR3.145-148 In vivo, CXCR3 
also gets rapidly internalized on memory CD8 T cells upon ligand 
exposure in the context of viral infections.171 However, to what level 
CXCR3 desensitization modulates T- cell migration in vivo during 
inflammatory conditions and how this contributes to pathogen re-
sistance remains largely unknown. Probably the best established ex-
ample for the physiological relevance of receptor desensitization is 
S1PR1. S1PR1 is essential for the exit of lymphocytes from SLO and 
the thymus.180 The ligand S1P is expressed by hematopoietic cells, in 
particular erythrocytes leading to high concentration in the blood. In 
order to generate a gradient, tissue expressed S1P lyases efficiently 
degrade S1P, thereby reducing its concentration in tissues. T cells 
express high levels of S1PR1 on their surface, but once they enter 
the blood stream, S1PR1 is rapidly down modulated, promoting T- 
cell entry into SLO.181 Within SLO, S1P concentrations are low, lead-
ing to re- expression of S1PR1 on the cell surface and lymphocytes 
regain the ability to exit SLO over time (for review182). Added to the 
cyclic surface expression pattern of S1PR1, also CCR7 surface ex-
pression appears to undergo a periodic pattern. In particular, it was 
found that CCL19 leads to receptor occupation and internalization of 
CCR7, functionally impairing its responsiveness in vitro.183 However, 
in CCL19- deficient animals lymphocyte dwell times in LN appear to 
be unaltered, so it remains to be shown if and to what level modula-
tion of CCR7 expression impacts on T- cell migration and in particular 
recirculation. By contrast, the functional relevance for CXCR4 re-
ceptor desensitization in vivo is more evident. In particular, a desen-
sitization resistant gain- of- function mutation of CXCR4 (CXCR41013) 
that underlies the WHIM syndrome in humans has been introduced 
into a mouse model.184 CXCR4wt/1013 heterozygous animals show 
reduced thymocyte and splenic T- cell counts, while absolute T- cell 
numbers were increased in LNs. These alterations in T lymphocyte 
trafficking between SLO and the blood could be normalized by 
CXCR4 inhibitors, underscoring the importance of CXCR4 and its 
desensitization for lymphocyte recirculation.
So how is GPCR desensitization regulated in T cells? Regarding 
S1PR1 desensitization the kinase GRK2 plays a central part.185 
Notably, GRK2 also regulates the desensitization of other chemo-
kine receptors like CCR5 in T cells.186 During chronic inflamma-
tory conditions in humans, GRK2 expression levels appear to be 
significantly reduced on T cells supporting the notion that GRK2- 
mediated GPCR desensitization plays an important role in T- cell traf-
ficking beyond recirculation. Counterintuitively, absence of GRK6, 
which is also highly expressed in T cells, strongly impairs CXCR4- 
mediated chemotaxis toward CXCL12 in vitro. This shows that 
GRKs work is a more complex fashion that likely goes beyond GPCR 
desensitization.187
Besides GRKs, a large group of RGS proteins is known to regulate 
GPCR signaling in lymphocytes.188 Several RGS proteins are highly 
expressed in lymphocytes. However, so far only RGS1 deficiency 
revealed a definitive role of these proteins in lymphocyte migration 
in vivo. Specifically, RGS1 reduces the sensitivity toward CXCR4 
and CCR7 ligands,189 and in particular regulates the trafficking and 
residency of T cells in the gut.190 Additionally, Trm show a signif-
icant upregulation of RGS1 compared to Tcm arguing for a more 
general function of this protein in regulating tissue residency of T 
lymphocytes.191
Changes in sensitivity toward a GPCR ligand can also be mod-
ulated	by	changes	in	GPCR	expression	levels	(Figure	2A).	 In	T	cells	
dynamic changes in GPCR surface expression is tightly connected to 
their biological function. We will discuss this in detail below as this 
involves multiple GPCRs. A special case is periodic changes in GPCR 
expression on lymphocytes in the context of the circadian rhythm. 
These changes modulate the recirculation and migration pattern of 
lymphocytes and myeloid cells and therefore have a profound im-
pact on both innate and adaptive immune responses.192,193 This has 
been excellently reviewed elsewhere194 and will not be further dis-
cussed here.
In summary, there is robust in vivo evidence for the importance 
of GPCR desensitization regarding T- cell recirculation, yet to what 
level this mechanism regulates T- cell trafficking toward inflammatory 
F IGURE  6 Time- dependent changes in G- protein–coupled 
receptor (GPCRs) during activation of CD8 T cells. Evolution of the 
GPCR expression pattern of CD8 T cells after activation. The GPCR 
expression pattern of naive T cells (before activation) determines 
their search behavior for antigen- presenting DC. GPCRs expressed 
between d1 and d3 may help activate T cells to support their 
differentiation by promoting encounters with specific DC or by 
navigating them into distinct inflammatory environments within 
SLO (eg, toward licensed cDC1 that relay CD4- helper signals). 
GPCRs expressed during the effector phase help differentiated 
CD8 T cells to find target cells within infected tissues. GPCRs 
expressed in the memory phase determine the area of surveillance. 
Notably, the relative gene expression is shown on a population 
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chemokines in the context of infections still needs to be addressed 
in the future.
3.3 | Development and differentiation: it is (almost) 
all about time and space
Time- dependent changes in GPCR expression levels can be typically 
seen during development of cells and organs, but also during acti-
vation of cells in the context of inflammation, tissue damage, and 
infections. Time- dependent and spatial changes in GPCR signaling 
accompany T cells throughout their life time and help them to navi-
gate through tissues. Within tissues GPCRs help T cells to settle in 
specific niches that provide further instruction signals or direct them 
to target areas that require their specific effector function.
Upon arrival in the thymus, T- cell progenitors undergo a highly 
complex instruction regimen that will allow them to express and re-
arrange their TCR chains. T cells with an intermediate affinity to-
ward peptide bound MHC complexes are then further selected via 
processes called positive and negative selection.195 Importantly, the 
functional development and instruction of thymocytes to mature 
lymphocytes is reflected by a physical journey of these cells through 
the thymus. During this “round- trip” thymocytes start at the cortico- 
medullary junction, move to the thymic cortex and the subcapsular 
zone and then back to the cortico- medullary junction and the thymic 
medulla.196	From	here,	mature	thymocytes	exit	the	thymus	via	S1P-	
S1PR1 signals and commence their GPCR- dependent recirculation 
between the blood and SLO.197,198 Likewise, the migration within the 
thymus is dependent of the timed expression of chemokine recep-
tors in particular CXCR4, CCR7, and CCR9.196 CCR7 signals contrib-
ute to thymocyte transition from the cortico- medullary junction to 
the outer cortex199 and are critical for their migration back to the me-
dulla.200 Specifically CCL21Ser (and not CCL21Leu or CCL19) is the 
critical ligand for transition to the medulla and tolerance induction 
in T cells.201,202 CCR7 also cooperates with CXCR4 signals that me-
diate the migration to the thymic cortex203 while CCR9 plays a non- 
redundant role for the transition from the cortex to the subcapsular 
area.204 The differential role of these chemokine receptors during 
the migrational steps of thymocytes is reflected by their dynamic 
expression	pattern	during	the	developmental	stages	(Figure	2A).205 
Vice versa blocking the migration of thymocytes in turn alters the 
development of the thymus and its functional organization.196
After leaving the thymus T cells commence their recircula-
tion between SLO that is regulated by S1PR1 as discussed above. 
However, on the second look it becomes clear that multiple GPCRs 
are involved in this process that act in an opposing fashion. Once T 
cells enter the LN they stay for about 6- 24 hours depending on the 
cell type—CD4 T cells dwell shorter than CD8 T cells, and Tcm lon-
ger than naive T cells.206,207 As mentioned above, time- dependent 
resensitization of S1PR1 in SLO promotes the exit to the lymph over 
time. Interestingly, CCR7 heterozygous lymphocytes have short-
ened dwell times in the LN, while CCR7 overexpressing or S1PR1 
heterozygous T cells stayed significantly longer.208 This argues for 
a competitive situation between retentions signals (via CCR7 and 
CXCR4) and exit cues (via S1PR1) that determine overall T- cell dwell 
times	in	LNs	(Figures	3C	and	4).	Competitive	GPCR	signals	are	likely	
a typical scenario that T cells experience while exiting other tissues 
as well like the bone marrow or the thymus. But also during an im-
mune response, in particular T follicular helper cells (Tfh) are ex-
posed to competitive GPCR signals like CXCR5- and CCR7- mediated 
chemotactic cues.209 While it is highly likely that other T cells are 
similarly exposed to conflicting GCPR signals during inflammatory 
conditions, very little is known how such competition regulates lym-
phocyte trafficking in vivo.
Upon antigen- specific activation by DCs, naive T cells undergo 
dramatic transcriptional changes, proliferate vigorously, and differ-
entiate into a continuum of cellular states ranging from short- lived 
effector cells on one end to long- lived memory cells at the other 
end of the spectrum.210,211 Naive CD4 T cells are further specialized 
to develop into different classes of T- helper cell subsets like Th1, 
Th2, Th17, Tfh, and Treg cells as reviewed elsewhere.212,213 Notably, 
these different classes of T- helper cells reflect specialized cellular 
states that are geared toward combating different types of infec-
tions (intracellular pathogens, extracellular pathogens, parasites, 
and fungi), helping to produce neutralizing antibodies or controlling 
overt immune responses and immunopathology. Naturally, these 
tasks require the migration to different tissues, microanatomical 
niches, and specific inflammatory environments. In line with this no-
tion, different T- helper subsets express specific patterns of chemo-
kine receptors that predominantly guide them to the required target 
site.214 Over the last decade this has been intensively investigated 
for Tfh. Together, several studies have revealed a highly coordinated 
and finely tuned microanatomical positioning of these cells during 
an emerging antibody response.209,215 With regard to the developing 
immune responses that give rise to Th1, Th2, and Th17 cells much 
less is known in terms of how chemokines regulate the positioning of 
these cells during their priming and differentiation. Clearly, chemok-
ines play an important role here as well, as exemplified by the func-
tion of CXCR3 for Th1 differentiation.216 As Treg cells must be able 
to control the various flavors of elicited immune responses and their 
cellular representatives, Tregs must follow (or precede) different ef-
fector cells to their specific inflammatory sites and microanatomical 
niches.217,218 In order to do so, they partially adopt the transcrip-
tional programs of their respective T- helper cell counterparts.219-221 
Overall, temporal and spatial control of GPCR signaling in T cells is 
critical on two levels: (a) it guides their differentiation in SLO and (b) 
it directs them to and within inflamed tissues where they execute 
their	 specific	 functions	 (Figure	3E).	 In	 the	 following	 paragraph	we	
will focus on cytotoxic CD8 T cells, how their chemokine expres-
sion pattern changes during activation, in which way it differs among 
CD8 T cells subsets, and how it impacts on their differentiation.
Once naive CD8 T cells exit the thymus they commence their 
recirculation pattern through the body predominantly via the GPCRs 
CXCR4, CCR7, and S1PR1 as discussed above. Additionally and by 
contrast to naive CD4 T cells, naive CD8 T cells express high lev-
els of CCR9222,223 and intermediate levels of CXCR6.224 To date, the 
exact function of these chemokine receptors on naive CD8 T cells 
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remains unknown. Upon activation, CD8 T cells change their GPCR 
repertoire. During their differentiation into effector and memory 
subsets	specific	GPCR	patterns	are	established	over	time	(Figure	6).	
Accordingly, we can group different GPCRs based on their temporal 
expression pattern. We can further discern four phases during which 
GPCRs execute specific biological functions. Before activation, the 
time frame after activation but before T cells commence prolifera-
tion, T- cell effector phase, and T- cell memory phase. Naive T cells 
express GPCRs that are important for their recirculation but addi-
tionally may help them to efficiently detect antigen- presenting DC. 
In particular, CXCR6, Gpr183 (Ebi2), and CCR9 could support this 
process. Once a CD8 T cell has engaged an antigen- presenting DC it 
co- arrests and interacts with it for several hours.225-228 This activa-
tion process is accompanied by the expression of additional GPCRs 
while the expression of other GPCRs may be shutdown. Upon dis-
engagement from the DC, now activated CD8 T cells become recep-
tive to a newly formed inflammatory and chemotactic environment 
and change their localization within the reactive lymph node. This 
in turn will influence their interaction partners in particular cDC 
over the following day before they proliferate and exit the lymph 
node. Importantly, there is strong evidence that T cells integrate 
these consecutive interactions with DC following the initial priming 
step.172,229,230 Therefore, both the initial priming and the consecu-
tive encounters of CD8 T cells with DC will shape the size and the 
differentiation of the ensuing CD8 T- cell response. The chemok-
ine receptors that are upregulated during this phase are CCR5 and 
CXCR3. Similar as in pDC as we will discuss below, these chemokine 
receptors appear to direct T cells to different localizations of the 
lymph node. Specifically, several studies have indicated that CCR5 
guides CD8 T cells to receive helper signals by licensed DC.178,231,232 
We and others have shown that in particular cDC1 relay these helper 
signals and are located in deeper paracortical areas.169,229,233 By con-
trast CXCR3 appears to guide CD8 T cells to the subcapsular sinus of 
the lymph node and promotes effector T- cell generation.170,171,234,235 
How activated CD8 T cells navigate within inflamed tissues (includ-
ing the lymph node) through complex chemokine fields and in which 
situations CCR5- and CXCR3- mediated signals are rather synergistic 
than conflicting remains largely unknown.236,237
By the time that T cells have fully adopted their effector pro-
gram and leave the lymph node they express additional inflamma-
tory chemokine receptors like CCR2 and CX3CR1. While CXCR3 
and CCR5 are expressed by the majority of CD8 T cells at the peak 
of an immune response, CX3CR1 shows a bimodal expression 
pattern with about half of the CD8 T cells expressing this GPCR. 
Interestingly, the expression pattern of CX3CR1 strictly correlates 
with cytotoxic effector molecules like Prf1 and GrzmB.238,239 
Importantly, CX3CR1 expression not only correlates with a spe-
cific effector function but also delineates a specific migratory be-
havior. It was recently shown that CX3CR1hi effector memory CD8 
T cells predominantly scan blood vessels rather than migrating 
within specific tissues with the exception of the spleen. By con-
trast, CX3CR1int memory CD8 T cells that have been termed Tpm 
(peripheral memory T cells) appear to migrate through peripheral 
tissues and enter lymph nodes via afferent lymphatics rather than 
HEV.240 GPCRs that help T cells to extravasate into inflamed tis-
sues often act in a redundant manner while in other cases they 
work	synergistically	 (Figure	3B).	Typically,	one	chemokine	recep-
tor can bind to multiple ligands and vice versa one ligand can be 
bound by multiple receptors.241 In vitro there are several examples 
of GPCR synergy (for review see242).	For	T	cells	in	vivo	there	are	
only few examples supporting synergy (rather than redundancy) 
between	chemokines.	For	example,	CCL5	and	CXCL10	have	been	
shown to synergize in promoting T- cell extravasation, yet in a 
somewhat articial model using intradermal injection of chemok-
ines.243 Besides synergy between CCR5 and CXCR3, other GPCR 
pairs are likely to cooperate in T cells as CCR7 and CXCR4, CCR2 
and CCR6, or CCR4 and CCR8. Overall, time- dependent changes 
in GPCR patterns in T cells are tightly connected to their specific 
function, guide them through their developmental steps, and nav-
igate them to and within inflamed tissues. However, how T cells 
traffick through complex chemokine fields while utilizing multiple 
GPCRs that may act in synergy or in antagonism is highly complex 
and is largely unknown.
4  | DENDRITIC CELL S
Conventional DCs (cDC) may be regarded as central inducers of 
adaptive cellular immune responses. DC express a variety of recep-
tors that allow them to sense infections, cellular damage, and meta-
bolic changes.244-246 Additionally, as phagocytes, DC are able to 
take up antigen, digest and process it so that it becomes detectable 
for T lymphocytes in the context of MHC molecules.247 Reflective 
of these biological functions, DC are able to integrate inflamma-
tory and antigenic information and translate them into appropriate 
output signals which initiate a suitable immune response.248 With 
regard to GPCR- mediated navigation a key feature of DCs is their 
migration from peripheral tissues to draining LNs in the context of 
their functional maturation.249 In contrast to T cells which are geared 
to search large tissue volumes, DC need to migrate and to settle 
within specific anatomical niches of SLO in order to be efficiently 
encountered by T cells or to be strategically positioned for optimal 
access to antigenic material.250 In mice and humans, DC comprise a 
rather heterogenous group of cells with differential localization in 
tissues, different migratory behavior, and functional specialization. 
We currently discern four major groups of DC,251 cDC that are fur-
ther subdivided in cDC1 and cDC2, plasmacytoid DC (pDC) that are 
characterized	by	their	ability	to	produce	large	amounts	of	IFNI	allow-
ing them to support both innate and adaptive immune responses,252 
and monocyte- derived DC (MoDC) that play a critical role during 
bacterial infections and coordinate effector responses in tissues.253 
Monocytes can differentiate into DC on- site following their immi-
gration into inflamed tissues, yet their exact function regarding the 
development of adaptive immune responses is still under debate.254 
Overall, in order to fulfill their central function in lymphocyte acti-
vation, GPCR mediated navigation is a critical requirement for DC.
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In vitro assays have been widely used to study DC migration in 
order to measure their responsiveness toward specific chemoattrac-
tants, to determine downstream signaling events and to identify crit-
ical molecules that are involved in DC locomotion.16,255,256 Most of 
these assays used human MoDCs or mouse bone marrow–derived 
DC (BMDC) to study their chemotactic responses. BMDC are a very 
popular immune cell type to study chemokine sensing and cytoskel-
etal dynamics due to their pronounced lamellopodia and actin- based 
protrusions. However, they are also seen critical because BMDC cul-
tures comprise highly heterogeneous myeloid cells that only in part 
resemble DC.257 Studies on GPCR- controlled DC migration mainly 
focus on the chemokine receptor CCR7, which becomes highly up-
regulated on DCs upon maturation. Moreover, inflammatory sig-
nals promote CCR7 oligomerization and promigratory signaling 
responses in DCs.39 CCR7 binds two ligands, the chemokines CCL19 
and CCL21, which differ structurally.258 CCL21 harbors a unique ex-
tended C- terminal tail that is negatively charged due to stretches 
of basic amino acids. This allows CCL21 to bind and become immo-
bilized to GAG with high affinity, with the potential to form hapto-
tactic gradients.6 In contrast, CCL19 lacks this C- terminus and is 
hence considered to diffuse and form soluble chemotactic gradients. 
In comparison, CCL21 can form steeper gradients than CCL19.259 
Transferring the CCL21 tail to CCL19 increases GAG binding of 
CCL19,260 whereas CCL21 becomes more soluble upon removal of 
its C- terminus.261 Interestingly, DC themselves can proteolytically 
cleave CCL21 to remove its C- tail, turning it into a more diffusible 
chemotactic molecule.46,261 Besides these differences in gradient 
formation, it is now also acknowledged that CCL19 and CCL21 bias 
CCR7 downstream signaling, desensitization, and receptor dynam-
ics in distinct ways.262-265 Thus, these aspects of CCR7 functional-
ity have received much attention and spawned the development of 
various in vitro assays, now allowing the analysis of DC migration 
in various experimental settings including 3D gels with soluble gra-
dients of altered shapes,256,266-268 substrate- bound gradients,269 or 
combinations thereof.270 DC navigation in the presence of multiple 
chemotactic cues mostly focused on competing fields of CCL19 and 
CCL21.46,52,270,271	 From	one	of	 such	 studies	 emerged	 the	 concept	
that local soluble CCL19 gradients can direct DC haptokinesis on 
immobilized CCL21.46 In addition to CCR7, other GPCRs including 
CXCR452,272,273 and S1P receptors274 are also functionally relevant 
for DC migration. When chemoattractive potencies were matched, 
DCs were found to home to central regions in opposing gradients 
of the CXCR4 ligand CXCL12 and CCR7 ligands.52 In the following, 
we will discuss what we have learned from in vivo studies regarding 
GPCR- guided DC navigation.
4.1 | Interstitial dynamics: from sessile networks to 
highly directed pathfinders
In contrast to lymphocytes, chemokinesis appears to play a minor 
role	 for	 the	migration	of	cDC	 in	 the	steady	state	 (Figure	1A).	 cDC	
rather form a sessile network275 in the lymph node, while newly ar-
riving DC immigrants from the blood or the lymphatics are rapidly 
directed to their respective niche by chemo- and haptotactic sig-
nals	 (Figure	1B).	However,	 there	 are	 some	 notable	 exceptions	 like	
CCR6- mediated chemokinesis that leads to the accumulation of cDC 
around small airways in the lung in the context of inflammation.276 
With regards to their steady- state migration but also their morphol-
ogy, pDC represent a somewhat intermediate cell type between lym-
phocytes and cDC. In LNs, pDC migrate in a chemokinetic manner 
similar to lymphocytes albeit at a significantly reduced speed (5μm/
min) and with less spatial displacement over time.172 The molecules 
that regulate LN entry and chemokinetic pDC migration in vivo are 
CCR7 and CXCR4.277,278
The first direct evidence for haptotaxis in guiding leukocyte 
migration in situ was provided in the context of cDC intravasation 
into	 lymphatic	vessels	 (Figure	1B).6,279 Sixt and coworkers directly 
visualized CCL21 in ear skin whole mounts and showed that it 
forms steep gradients around lymphatic vessels. Cells with a suffi-
cient size (like cDC) are able to spatially sense such gradients and 
migrate directionally toward lymphatic vessels. Importantly, CCL21 
is physically attached to the ECM via binding to heparan sulfates 
and removal via heparitinase altered CCL21 patterning and dimin-
ished cDC migration. As almost all chemokines have GAG- binding 
properties, haptotaxis might be a more generally utilized principle 
for	 immune	 cell	migration	 and	 in	particular	 for	 cDC.	For	 example,	
once DC intravasated into the lymphatic vessel, they follow a lymph- 
flow induced haptotactic CCL21 gradient until they detach and get 
passively carried to the dLN.280 When cDC arrive in the dLN they 
likely follow CCR7- mediated haptotactic cues in order to enter the 
LN parenchyma.281 In line with this notion expression of the atypical 
chemokine receptor ACKR4 within the lymphatic endothelium has 
been shown to be critical to shape a CCL21 gradient across the sinus 
floor.7 In the absence of ACKR4 migratory DC get trapped within 
the SCS and fail to enter the LN parenchyma. Haptotactic cues are 
probably not only guiding cDC to the LN but also help them to find 
their specific niche within SLO. However, this intranodal trafficking 
of cDC may also be a combination of haptokinetic and chemotactic 
signals as we will discuss in more detail below.
4.2 | Orientation in the tissue: Is it all about CCR7 
functionality?
In general, cDC immigrate to LNs via two separate entry points. (a) 
DC precursors that are released from the bone marrow enter the LN 
via high endothelial venules (HEV) in a CCR7- dependent manner. (b) 
Tissue residing cDC, in the context of their maturation, upregulate 
CCR7 and migrate to lymphatics and enter the LN via the SCS and 
the interfollicular area of the LN. In this section we will focus on 
DC migrating from tissues to LNs as a prime example of temporal 
changes in single GPCR expression that regulate cellular migration 
(Figure	2A).282
In the steady state DC undergo a complex maturation pro-
gram that largely overlaps with pathogen- induced maturation.283 
This homeostatic maturation of DC is operative in the absence of 
microbiota	or	 IFN	I	signaling,	but	depends	on	NF-	kB	activation.284 
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A central element of the maturation process is the upregulation of 
CCR7.285,286 CCR7 is absolutely required for the migration of cDC to 
draining LN in the steady state and during inflammation.287 Notably, 
dermal DC that enter the LN at the interfollicular zone, settle in the 
outer- paracortical region that is rich for HEV, thereby enhancing the 
likelihood to engage with newly arriving T cells that enter the LN 
from the blood stream via HEV.288 By contrast dermal Langerhans 
cells (LC) migrate further into the LN and settle within the deep para-
cortical region.289
Besides migration to SLO, CCR7 upregulation appears to further 
regulate migration within SLO. In the context of systemic infections, 
cDC1 translocate from the red pulp to the white pulp of the spleen 
while cDC2 migrate from the bridging channels toward the white 
pulp.49,166 Within LNs, cDC1 translocate from the interfollicular area 
to the paracortex upon viral infections, which again is likely medi-
ated via CCR7.172 By contrast, LN- resident cDC2 translocate to the 
medullary area and then further to the interfollicular zones to acti-
vate CD4 lymphocytes in context of influenza infections.290 While 
some GPCR like GPR183, CXCR5, and XCR1 help to lodge DC into 
specific niches of the LN or direct them to certain areas upon inflam-
mation, DC migration is overall dominated CCR7- mediated signals 
and consequently by changes in surface expression of this recep-
tor. As during lymphocyte recirculation, receptor desensitization 
adds an additional layer fine- tuning the regulation of DC migration 
(Figure	2D).	Homologous	desensitization	for	CCR7	that	is	highly	rel-
evant for DC trafficking has been shown to be ligand dependent. In 
the case of CCL19, both GRK3 and GRK6 are activated leading to 
CCR7 internalization and recycling and overall to receptor desen-
sitization.263,291 By contrast CCL21 only activates GRK6 and does 
not induce receptor internalization arguing for an alternative way of 
CCR7 desensitization.265 In vitro, GRK6- deficient DC failed to mi-
grate toward haptotactic cues in particular at low CCL21 concentra-
tions. In vivo, the situation is less clear. While fewer GRK6- deficient 
DC are able to immigrate into ear skin explants than WT DC, these 
KO DC intravasated more efficiently into the lymphatic vessels.269
Upon GRK- mediated phosphorylation of the GPCR, arrestins 
get recruited initiating the actual desensitization process.292 In 
particular, β- arrestin 2 has been shown to regulate the sensitivity 
toward	CCR7	and	CXCR4	mediated	cues.	Functionally,	β- arrestin 2 
deficiency in DC resulted in enhanced steady- state migration to SLO 
and aggravated disease status in various autoimmune models.293 On 
a molecular level, β- arrestins, like GRKs seem to act beyond receptor 
desensitization leading to more complex phenotypes that cannot be 
explained by alterations in migratory behavior alone.
In summary, modification of GPCR surface expression and sensi-
tivity regulation are integral elements of DC migration and function, 
allowing them to mount and fine- tune adaptive immunity toward in-
fections via compartmentalization of leukocyte interactions.294
As discussed above, the migration of DC from tissues to the dLN 
is a process that is dominated by CCR7- mediated guidance cues. But 
not only CCR7 is dominant as a receptor also regarding its ligands 
CCL19 and CCL21 there is a clear hierarchy in vivo. In particular, it 
was shown that CCL19- deficient animals show normal DC migration 
to and localization within LNs.295 However, regarding the migration 
to LNs there are two interesting situations that require additional 
synergistic and sequential GPCR signals for efficient trafficking 
to	the	LN	(Figure	3B,E).	One	example	are	LC	that	first	need	to	de-
tach296 from the epidermis and as an initial migratory step, need to 
cross the basal membrane and migrate to the dermis. This primary 
migratory event appears to be independent of CCR7 but rather uti-
lizes various context- dependent GPCRs.297-299 While LC migrate to 
the dermis they upregulate CCR7 and enter lymphatic vessel simi-
lar to cDC in a secondary migratory step. Consequently, LC require 
significantly more time to emigrate from the skin than dermal cDC. 
Interestingly, it has been recently demonstrated that a subset of der-
mal DC also shows a two- step migration pattern.300,301 In particu-
lar, CD301b expressing dermal DC require CCR8 in the context of 
Th2 priming conditions in order to cross the subcapsular sinus of the 
LN. In this situation, CCR8 does not promote chemotaxis itself but 
rather potentiates the effect of CCR7- mediated migration. A sim-
ilar requirement for CCR8 has been observed for the migration of 
moDC from the skin to draining LNs.302 However, why the migration 
of CD301b DC and moDC, in contrast to other dermal DC subsets, 
is regulated via this second migration step and why CCR7- mediated 
signals are sufficient to drive emigration of these DC from the skin, 
yet insufficient to promote the full immigration to the LN requires 
further investigations.
While DC migration to the dLN is overall dominated by CCR7,303 
in tissues multiple GPCRs can get activated in order to lodge DC 
into their optimal niche. This lodging within tissues could be based 
on chemotactic signals on top of CCR7- mediated haptokinetic cues 
(Figure	3A,B,E).	Some	prominent	examples	are	(a)	GPR183-	mediated	
migration, which navigates cDC to the bridging channel in the spleen 
or the T/B border of the LN,167,168 and (b) the CXCR5- dependent cDC 
migration to the interfollicular and subcapsular sinus area of the LN 
in the context of H.pylori infections,304 as well as (c) CCR6- mediated 
guidance of cDC to the subepithelial dome of Peyer's patches305 and 
(d) cDC migration from the subepithelial dome to the T/B border 
upon activation and infection306 or (e) intranodal migration of cDC1 
toward activated CD8 T cells following a gradient of XCL1172 and 
skin DC clustering around macrophages based on CXCL2- mediated 
recruitment.307 In order to resolve the exact mode(s) of migration in 
these scenarios, it will be required to determine whether the chemo-
attractants at play are soluble or immobilized and how DC interpret 
combinations of chemokines in these situations.
In contrast to cDC that predominantly express homeostatic 
GPCRs, pDC are additionally equipped with inflammatory GPCRs 
like CCR2, CCR5, and CXCR3. This is reminiscent to NK cells, ILC1, 
Th1 cells, and effector CD8 T cells, cell types that cooperate to 
eliminate intracellular pathogens. In the steady state pDC that re-
side in SLO are primarily localized in the paracortex, yet appear to 
be enriched at the interfollicular area of the LN similar to memory 
CD8 T cells.170,172 Interestingly, when we analyzed the migratory 
behavior of pDC during viral infections, we found that pDC accumu-
late at two different anatomical sites of the LN already a few hours 
after infection. One group of pDC migrates to the subcapsular sinus 
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area where they interact with virally infected sinus- lining macro-
phages.172,308 By contrast, a second group of pDC migrates toward 
recently activated CD8 T cells that interact with antigen- presenting 
cDC. Mechanistically, these sites emit different chemokine cues ex-
posing	the	responding	cells	to	competitive	signals	(Figures	3C	and	4).	
The	SCS	area	releases	IFN-	induced	CXCR3	ligands	(CXCL9,	CXCL10,	
and CXCL11) upon viral infection. While activated CD8 T cells pro-
duce CCL3 and CCL4 that recruit pDC via CCR5. Interestingly, this 
migratory ambivalence also reflects two different biological func-
tions	of	pDC.	CXCR3-	guided	pDC	release	IFNI	at	the	site	of	infection	
in order to limit viral replication and dissemination. CCR5- guided 
pDC	release	IFNI	at	the	site	of	CD8	T-	cell	priming,	which	promotes	
the maturation and cross- presentation capacity of cDC1. In other 
words, one group of pDC serves an innate function, while another 
group supports adaptive immunity—notably via the same effector 
function, yet within different microanatomical compartments. This 
dichotomous navigation of groups of cells between conflicting sig-
nals was not only seen for pDC but also for other cell types that are 
equipped with the same GPCRs like NK cells (unpublished obser-
vation W. Kastenmuller). This poses the question how the immune 
system generally operates in order to ensure rapid and robust ar-
rival of one cell type at two different sites within a tissue? A strictly 
hierarchical system is not in line with the observed phenotype be-
cause	it	would	predict	that	all	cells	end	up	at	one	site	(Figure	4A).	So,	
some decision process is required assuming that both GPCRs are ex-
pressed at a functional level, otherwise cells could get paralyzed or 
disorientated	between	opposing	gradients	(Figure	4B).	While	CCR5	
and CXCR3 drive pDC to different areas of the inflamed LN, these 
same GPCRs rather show synergistic functions on T cells.237 On the 
other hand, it is quite likely that cell type–specific differences exist 
and that some GPCR's synergize in one cell type, yet may have cross- 
inhibiting functions in others. In fact, even on a single cell level, het-
erogeneity between cells may contribute to the “decision- making” 
process	in	conflicting	chemokine	fields	(Figure	4C).	The	assumption	
that both GPCRs (CCR5 and CXCR3) are expressed homogenously 
on pDC is rather unlikely and instead a range of expression patterns 
across a population may underlie the single cell behavior seen in vivo. 
In other words, pDC may not integrate opposing signals while they 
migrate through tissues but are rather geared to preferentially follow 
certain cues a priori. This preference may be further hard wired by 
downstream or inhibitory molecules of the respective GPCR signal-
ing pathway.
While some chemokine gradients may drive DC to opposing 
sites, others may synergize to optimize the recruitment process 
(Figure	3A,B).	 However,	 it	 is	 often	 difficult	 to	 discern	 between	
redundancy vs synergy of GPCRs as many in vivo studies rely on 
end- point analyses of gene- deficient animals. However, there are a 
couple of examples that likely reflect synergistic effects of GPCR 
signaling in guiding DC migration in vivo. It has been shown that the 
abundance of cDC1 and expression of CCR7 within tumors is a prog-
nostic marker of clinical outcomes.309,310 Recent evidence supports 
a critical role for intratumoral NK cells in recruiting cDC1 within the 
tumor which is essential for effective immune responses against 
cancer.311 This recruitment appears to be based on synergistic ef-
fects of NK cell- derived CCL5 and XCL1. Another example is the 
role of CCL17 for DC emigration from the skin in the context of Th2 
responses.299 In vitro, DC- derived CCL17 synergizes with CCR7- 
mediated signals to optimize directionality and speed of DC migra-
tion. Mechanistically, this synergistic effect is not based on altered 
surface expression of CCR7 in the presence or absence or CCL17 
but rather on downstream signaling events involving enhanced Ca2+ 
flux. In vivo this results in a significant reduction in DC migration to 
dLN	in	the	absence	DC-	derived	CCL17.	Finally,	pDC	trafficking	into	
the white pulp of the spleen was shown to be based on a cooperative 
action between CCR7 and CXCR4.277
Overall cDC migration seems to be dominated by CCR7- 
mediated navigation reflecting the functional maturation of DC and 
trafficking from tissues to dLNs.249 However, at a closer look we find 
that DC fine- tune their migratory behavior using multiple GPCR in 
order to populate specific microanatomical niches that are critical 
to mount adaptive immunity or to orchestrate effector responses in 
tissues.172,307,311
5  | CONCLUSION
In vivo cellular migration is a highly complex process and we observe 
different migratory patterns dependent on the chemoattractant, the 
engaged GPCR, intracellular regulatory proteins, the leukocyte sub-
set, and the nature of the tissue. Some of the observed migratory 
patterns can be well explained by single GPCRs that may dominate 
under specific conditions. In reality, however, there are typically sev-
eral GPCRs engaged simultaneously or sequentially and the respond-
ing cells need to integrate these signals. Some of these signals may 
be synergistic, while others are conflicting. Adding to the intricacy 
is the fact that some chemokines are agonistic to one receptor, yet 
maybe antagonistic to another one.312 Additionally, MMP- mediated 
degradation of agonistic chemokines can result in products that are 
antagonistic to the same chemokine receptor.313 This raises impor-
tant questions on how cells navigate through complex GPCR fields 
without getting trapped and paralyzed between opposing signals or 
get distracted and follow the wrong path. What is the role of single 
cell heterogeneity to promote flexibility of the system without sacri-
ficing its robustness? Dynamic changes in GPCR expression patterns 
upon cellular activation and concomittant alterations of chemotactic 
cues and biophysicial features of inflamed tissues add yet another 
layer of complexity that cells need to resolve in order to be guided to 
the right location in the shortest amount of time.
Biologically, navigation of leukocytes through inflamed tissues 
to infected sites and local execution of their specific effector func-
tion and importantly also termination of such a response reflects 
the balance between pathogen clearance and tissue damage. It is 
this very balance that determines the healthy vs the diseased state 
of an individual. Revealing how leukocytes exactly regulate their 
trafficking through complex chemoattractant fields will be ex-
tremely challenging. On one hand we lack information regarding 
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the precise nature of the chemokine fields at work. How many cells 
produce a given chemokine during a specific time frame? How long 
does the chemokine gradient remains active? How do secondary 
changes (degradation, modification, or consumption) impact on the 
chemokine gradient? Novel optogenetic tools may provide us with 
the capability to sharply control chemokine release in situ.314 With 
such approaches we will be able to directly control and experimen-
tally influence leukocyte migration in vivo instead of being mere 
observers. On the other hand, we still lack detailed data on how 
specific GPCRs modulate the migratory behavior of different cell 
types in different tissues. In many studies the migratory behavior 
of leukocytes is not directly visualized. Instead, conclusions were 
drawn based on “end- point” differences using animals that are de-
ficient for a specific GPCR. Optimally, loss- and gain- of- function 
conditions should be visualized directly side- by- side in vivo. GPCRs 
coupled to fluorescent proteins will further allow us to visualize 
GPCR internalization and desensitization events. With new tools 
being developed, continuous technical advancements in intravital 
microscopy and artificial intelligence supporting the analysis and 
modeling of imaging data we are confident that many obstacles will 
be overcome.
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